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Pathogenic characteristics of Candida albicans isolated from oral cavities of denture 
wearers and cancer patients wearing oral prostheses. 
 
CHAPTER 1  
INTRODUCTION AND LITERATURE REVIEW 
 
Introduction 
Candida albicans is a normal commensal carried by human in the oral cavity, digestive system 
and vagina. It can cause superficial to systemic opportunistic infection both in 
immunocompromised patients, hospitalized patients and otherwise healthy individuals. It has an 
ability to cause infection due to its virulence properties or pathogenic characteristics. These 
include the ability to adhere to host tissues and prostheses (eg. dentures), phenotypic switching, 
formation of germ tubes for tissue invasion and the production of a range of hydrolytic enzymes 
such as tissue damaging proteinases and phospholipases (Khan et al., 2010 and Samarananyake, 
2002). During commensal and disease state, the number of C. albicans and their virulence in the 
oral cavity may fluctuate depending on the oral status, patient’s general health, intake of 
antibiotics, the presence of prostheses and onset of candidiasis. The number and the virulence of 
this organism may act as a marker for the onset of disease process. This study investigated the 
virulence properties of C. albicans isolated from the oral cavities of healthy subjects and two 
vulnerable groups, denture wearers and cancer patients wearing oral prostheses.  
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1 Literature review 
1.1 Candida species 
Yeasts which belong to the genus Candida consists of imperfect unicellular dimorphic fungi 
which multiply by budding similar cells from their surface and form hyphae and/or 
pseudohyphae. They were earlier assigned to the family Deuteromycetes, indicating a lack of 
sexual reproduction. However, several pathogenic and non-pathogenic Candida species has been 
identified to have sexual reproduction (Webb et al., 1998).  
 
Macroscopically, Candida spp. form cream-coloured colonies with a sour yeasty odour when 
grown under aerobic conditions on medium which has a pH range of 2.5-7.5 and a temperature 
range of 20-38°C. Growth is always detected in 48-72 hours, and on sub-culture may grow more 
rapidly. The ability of yeasts to grow at 37°C is an important characteristic to be considered in 
their identification from clinical specimens as most pathogenic species grow readily at 25°C and 
37°C. Microscopically, all yeasts species are similar, Gram-positive but sometimes the shapes of 
the blastospores can vary from void to elongated or spherical. Candida albicans exhibits 
dimorphism with transition from ovoid budding blastospores (yeast cells) to parallel-sided 
hyphae (Webb et al., 1998). 
  
The yeast exhibits a number of different morphological forms under different environmental 
conditions; i.e. budding yeast cell (blastorespore, blastoconidia) pseudohyphae, true hyphae and 
clamydospores (Figure 1.1). A hypha has been defined as a microscopic tube which contains 
multiple cell units divided by septa and which may arise from existing hyphae or from 
blastospores. They are known as germ tubes and grow continuously by apical extension. When 
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blastospores are produced in linear fashion without separating, a structure termed pseudohypha is 
formed. True septate hyphae are produced by some Candida species, such as C. tropicalis, under 
certain circumstances, but true hyphae are associated with C. albicans. The entire candidal 
cellular aggregate including hyphae, branches and lateral buds are referred to as a mycelium 
(Webb et al., 1998). The transition between these different morphological forms in response to 
diverse stimuli seems to be very important for fungal pathogenicity. Their morphology can 
change under a variety of environmental conditions, including response to physiological 
temperature of 37
o
C, a pH 7.0 or higher, CO2 concentration of 5.5% or the presence of serum or 
carbon sources which stimulate the hyphal growth. The production of unicellular form is 
stimulated by low temperatures and acidic pH, absence of serum and high concentrations of 
glucose, (Karkowska-Kuleta et al., 2009). 
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Figure 1.1 Growth forms of Candida species. [Source: Calderone (2002)] 
 
 
 
1.1.1 Candida albicans 
The fungus known as C. albicans was first isolated by Bennett in 1844 from the sputum of a 
tuberculosis patient (Collier et al., 1998). It is a human commensal that is also an opportunistic 
pathogen. Between 18% and 40% of individuals carry C. albicans in their oral cavity (Odds, 
1988) and although predominantly associated with the dorsum of the tongue, it can be cultured 
from saliva, and from swabs of the cheek and tooth surfaces (Arendorf and Walker, 1980). 
Coccal Yeast 
Hyphae formation 
Pseudohyphae formation 
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However, it survives poorly on dry surfaces (Odds, 1988) and can be viable for some time on 
moist objects. For example, it is isolated from the toothbrushes of most people who carry the 
yeast in their mouths, and survives in hand cream, cosmetics and on clothing (Cannon et al., 
1995). 
 
It is an oval, budding yeast-like fungus producing both blastospores and pseudomycellium in the 
tissue and exudates, and can be cultured at room temperature and at 37
0
C. The most valuable test 
for rapid presumptive identification of C. albicans is the Germ Tube Test (GTT). Microscopic 
observation of the preparation will reveal that the short hyphal initials produced by C. albicans 
are not constricted at the junction of the blastoconidium and germ tube. Frequently, so many C. 
albicans blastoconidia, i.e. the unit of asexual reproduction produced by budding, also called 
blastospore, produce germ tubes that become entwined with each other, producing clumps of 
cells (Collier, 1998). Germ tube formation is the initial stage in the yeast-hyphal transition. The 
presence of hyphae seems to facilitate the candidal colonization on the mucosal surfaces and 
raises the C. albicans counts (Bilhan et al., 2008) and therefore, it is considered as one of the 
pathogenic characteristics. 
 
C. albicans is the most prevalent yeast isolated from the human body as a commensal or as 
opportunistic pathogens (Cannon et al., 1995). However, many Candida species other than C. 
albicans also exist on the human host and cause opportunistic infections. 
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1.1.2 Pathogenic Candida species other than C. albicans 
The genus Candida is comprised of about one hundred and fifty species including C. albicans, C. 
tropicalis, C. parapsilosis, C. krusei; C. kefyr, C. glabrata, and C. guilliermondii which are 
recognized as medically important pathogens causing diseases ranging from superficial mycoses 
to fatal infections (Cannon et al., 1995a). Candida species implicated in the development of oral 
candidiasis include C. tropicalis (2%), C. glabrata (15%), C. parapsilosis (15%), C. 
guilliermondii (6%) and C. krusei (1%) (Akpan and Morgan, 2002). Candida dubliniensis is 
often found in immunocompromised such as the elderly and HIV patients, and is found only in 
about 3.5% of healthy subjects.  
 
Candida is the fourth most common cause of hospital-related bloodstream infections. Forty 
percent of patients who have Candida in their intravenous catheters have underlying fungemia 
while the case-fatality rate for catheter-related candidemia approaches 40% (Kuhn et al., 2004). 
The infections caused by Candida spp. result in increased length of hospital stay and medical 
costs that constitute an important public health problem (dos Santos, 2010).  
 
According to Meurman et al., (2007), C. glabrata is considered a pathogen that causes infection 
only when detected with C. albicans. There have been several reports on oropharyngeal Candida 
(OPC) infections due to C. glabrata and it is now emerging as an important pathogen in both 
mucosa and bloodstream infections. It is commonly isolated from the oral cavities of HIV-
infected individuals and it is the second-most common agent of candidemia in the United States 
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since the early 1990s. Candida glabrata associated with OPC infections in HIV- and cancer 
patients are more severe, more difficult to treat and are associated with systemic infections with a 
high mortality rate (Meurman et al., 2007). 
 
Although C. parapsilosis is found as a commensal, it is the second most important pathogenic 
yeast of the Candida species (Kuhn et al., 2004, Ozkan et al., 2005). It often causes systemic 
infections especially related to foreign body insertions, neonates and hyperalimentation and 
particularly affects critically ill neonates and surgical intensive care unit (ICU) patients 
(Meurman et al., 2007). Candida tropicalis is found in 10-30% of non- C. albicans Candida 
(NCAC) infections and it is becoming an emerging pathogen globally. It is also detected in 
patients with neutropenia and bone marrow transplantation. The major contributory factors in the 
emergence of C. tropicalis include the increasing use of an antifungal regimine, the increasing 
number of immunocompromised patients, long-term use of catheters and complexity in treating 
underlying subclinical conditions coupled with antifungal drug intolerance (Meurman et al., 
2007). 
 
Candida famata is considered as an emerging pathogen associated with a range of conditions 
such as eye infections, intravenous catheter infections, fungemia and peritonitis in humans, 
particularly in immunocompromised patients. Although it has been isolated from foods, and 
human and animal tissues, it has been poorly studied (Pacheco et al., 2007). Candida 
guilliermondii has been documented to cause infection in patients undergoing surgical 
procedures, cause endocarditis in intravenous drug users and fungemia in immunocompromised 
patients. It has also been isolated in urinary tract infections. Candida krusei causes infection 
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mainly in the critically ill patients and is most often isolated from hematology patients with 
severe neutropenia (Meurman et al., 2007). 
 
1.1.3 Colonization of Candida albicans in the oral cavity 
Many healthy subjects carry C. albicans in their oral cavity. Colonization with C. albicans can 
lead to systemic infection when the host presents risk factors. Predisposing factors for 
colonization and candidiasis include immunosuppressive and cytotoxic therapies, treatment with 
broad spectrum antibiotics, AIDS, diabetes, drug abuse, use of catheters and indwelling devices. 
Depending on the underlying host defects, the microorganism may cause a wide variety of 
infections ranging from mucosal to life threatening disseminated candidiasis. Development of 
candidiasis depends on a delicate balance between the commensal or parasitic relationship 
(Mishra et al., 2007, Brawner and Cutler, 1989).  
 Once in the mouth, C. albicans is presented with a plethora of sites for adhesion to oral surfaces. 
These include the epithelial cells of buccal mucosae, the tongue, tooth surfaces, various oral 
prostheses such as dentures, and other oral micro-organisms that have already colonized these 
surfaces (Cannon and Chaffin, 2001). A warm, moist, generally nutrient rich environment is a 
situation that would enhance colonization. The growth in the oral cavity can be influenced by 
several factors such as temperature, redox potential/anaerobiosis, pH, nutrients (sugar, amino 
acids and peptides) and host genetics (Akpan and Morgan, 2002). Newborn usually become 
colonized with the mother’s vaginal flora or other exogenous sources. Most people are colonized 
with a distinct strain of Candida and if the infection occurs, the infecting strain is the same as the 
colonizing strain (Meurman et al., 2007).  
9 
 
Salivary gland dysfunction can predispose to Candida infection such as oral candidiasis. 
Secretion of saliva causes a washing effect and removes organisms from the mucosa. 
Antimicrobial proteins in the saliva such as lactoferrin, sialoperoxidase, lysozyme, histidine-rich 
polypeptides, and specific anticandida antibodies, prevent the overgrowth of Candida. Therefore 
conditions or drugs that reduce salivary secretions such as Sjögren’s syndrome, radiotherapy of 
the head and neck cancers, can lead to an increased risk of oral infections (Akpan and Morgan, 
2002).   
 
The prevalence of Candida in South African HIV-positive subjects was found to be significantly 
higher (75%) than in HIV-negative (68%) subjects (Hauman et al., 1993, Patel et al., 2006). In 
addition, HIV positive patients carry high quantities of Candida and variety of Candida spp. 
compared to the healthy individuals. Colonization rate in cancer patients is usually high and 
increases with radiation therapy. Head and neck radiotherapy and chemotherapy are associated 
with a significant increased risk for oral fungal infection. In patients receiving head and neck 
radiotherapy, the prevalence of clinical oral fungal infection was 7.5% pretreatment, 37.4% 
during treatment and 32.6% after the end of radiation therapy. Increased colonization during and 
after radiation therapy also leads to increased rates of clinical oral fungal infection (Bensadoun et 
al., 2011).  
 
In a study by Schelenz et al., (2011), it was discovered that oral yeast colonization varied 
amongst different cancer groups and was highest in solid tumor patients (colonization rate 
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64.6%) compared with hematological malignancies patients (49.4%) or head and neck cancer 
patients (36.9%). Bensadoun et al., (2011) also mentioned that a wide variety of Candida species 
are carried by these cancer patients, for example, in patients receiving chemotherapy and/or 
radiation therapy to the head/neck, the oral cavity of 46.2% of patients were colonized by C. 
albicans, 16.6% C. tropicalis, 5.5% C. glabrata and  3% C. krusei (Bensadoun et al., 2011).  
 
1.2 Oral candidiasis 
The term “Candidiasis” is used to describe a primary or secondary infection caused by yeasts 
that belong to the genus Candida (Sini et al., 2007). Candidiasis is common among very young, 
the elderly, particularly in denture wearers, and it is avoidable with a good oral and denture 
hygiene program (Akpan and Morgan, 2002). In addition, it is common in immunocompromised 
patients such as those infected with HIV, cancer patients on chemo and radiotherapy and patients 
with diabetes mellitus. Approximately 50 percent of people with complete upper dentures will 
suffer from Candida-related Stomatitis (chronic erythematous candidiasis) whereas 
oropharyngeal candidiasis, more serious illness is highly prevalent in AIDS patients. Up to 60% 
of healthy individuals carry Candida in their oral cavities without clinical symptoms, but usually 
the yeast is present in low numbers in comparison to oral bacteria (Cannon and Chaffin, 2001). 
 
1.2.1 Types of oral candidiasis 
Oropharyngeal candidiasis has been classified into different categories depending on the type of 
lesions (Figure 1.2). It includes acute pseudomembraneous, acute and chronic atrophic, chronic 
hyperplastic, median rhomboid glossitis and angular cheilitis (Akpan and Morgan, 2002).  
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Pseudomembranous candidiasis (thrush) is characterized by white pseudomembranes consisting 
of desquamated host epithelial cells and fungal growth. The curd-like patches occur on the oral 
mucosa, palate and tongue. The membrane can easily be removed with a swab to expose an 
underlying affected tissue (Akpan and Morgan, 2002). In acute atrophic candidiasis, patient 
experience burning sensation, particularly on the tongue with a bright red mucosa (Akpan and 
Morgan, 2002).  
 
In chronic conditions, hyperplastic candidiasis occurs as white lesions on the buccal mucosa or 
lateral part of the tongue which can progress to severe dysplasia and it is referred to as candidal 
leukoplakia (Akpan and Morgan, 2002). 
 
 
 
 
 
 
Figure 1.2 Classification of oral candidiasis [Source: Akpan and Morgan, 2002] 
 
Classification of Oral candidiasis 
 
1 Acute candidiasis 
 Acute pseudomembranous candidiasis (thrush) 
 Acute atrophic or erythematous candidiasis 
2 Chronic candidiasis 
 Chronic hyperplastic candidiasis or 
leukoplakia 
 Chronic atrophic denture related candidiasis 
 Median rhomboid glossitis 
        3 Angular cheilitis or stomatitis 
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Chronic atrophic candidiasis is characterized by localized chronic erythema of tissues underneath 
the dentures. Lesions usually occur on the palate and it can be diagnosed on the removal of 
dentures. Median rhomboid glossitis is a chronic symmetrical lesion on the center of the tongue 
anterior. In the 85% of cases Candida can be yielded from biopsies. It is often associated with 
steroid inhalation and smoking (Akpan and Morgan, 2002). 
 
Angular cheilitis is an erythematous cracking at corners of the mouth and is usually associated 
with oral Candida, Staphylococci and Streptococci. A constant moist environment in this area 
predisposes to this lesion. Long term denture wearers usually suffer more with this condition 
(Akpan and Morgan, 2002). 
 
1.2.2 Candida infections in denture wearers 
Dentures are prosthetic replacement for individuals who have lost some of or all of their natural 
teeth. They assist to restore chewing functionality, return a normal appearance to the facial 
structure and improve the patient’s ability to pronounce and enunciate during speech. For 
patients who are missing both maxillary (upper arch) and mandibular (lower arch) teeth, the use 
of complete dentures will give them a complete set of teeth. Dentures can also be constructed to 
replace only selected teeth on a particular arch. Fixed partial dentures are designed to replace 
missing teeth by cementing missing units with crowns cemented to appropriately prepared teeth 
(Zarb et al., 2013). 
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Wearing of dentures produces a suitable microenvironment for the growth of Candida with low 
oxygen and low pH (Akpan and Morgan, 2002). The development of oral candidiasis may be due 
to enhanced adherence of Candida species to acrylic, reduced saliva flow under the surfaces of 
the denture fittings, improperly fitted dentures, or poor oral hygiene (Gendreau and Loewy, 
2011). In addition, growth of Candida and adherence to oral epithelial cells is enhanced by a 
high carbohydrate diet (Akpan and Morgan, 2002). Plaque containing oral bacteria and Candida 
on the inner surface of the denture harbors microorganisms causing inflammation of the mucosa 
(Samaranayake, 2002). C. albicans is considered the most important Candida species
 
able to 
cause oral infections in denture wearers (Gasparoto et al., 2009). 
 
In patients wearing dentures, Candida seem to be an important factor in the formation of 
denture-related stomatitis (DRS), which is a common inflammatory process that mainly involves 
the palatal mucosa when it is covered by complete dentures. DRS attack the mucosal area 
adjacent to dental prostheses and beneath the fitting surface of the denture, especially the 
maxillary dentures (Gasparoto et al., 2009). The pathological reactions of the denture bearing 
palatal mucosa may be known as denture-induced stomatitis, denture sore mouth, denture 
stomatitis, inflammatory papillary hyperplasia and chronic atrophic candidosis.  
 
Denture-related stomatitis is still a dilemma in removable prosthodontics. Epidemiologic studies 
have shown that it is a relatively common fungal infection that affects approximately 50% to 
65% of denture wearers (Darwazeh et al., 2001, Akpan and Morgan, 2002). It occurs mostly in 
women and the prevalence increases with age. Clinically, the inflammation is of varying degrees 
and classified using Newton’s classification (Samaranayake, 2002).  
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There are different factors that cause denture stomatitis including traumatic occlusion, poor oral 
and denture hygiene, microbial factors and increased age of denture resulting in the accumulation 
of plaque on the denture, old age, dryness of mouth, systemic conditions, diabetes mellitus and 
immunodeficiency, nutritional deficiencies and medications (Naik and Pai, 2011,Gendreau and 
Loewy, 2011). 
 
According to Akpan and Morgan, (2002), oral hygiene and topical antifungal agents are 
generally adequate for uncomplicated oral candidiasis. Oral hygiene involves daily cleaning of 
the oral cavity, tongue and dentures. Acrylic dentures have irregular and porous surfaces which 
facilitate the adhesion of Candida and brushing alone cannot remove them. Therefore, at night 
removal and disinfection of dentures is important. After disinfection, dentures should be allowed 
to air dry to kill adherent Candida on dentures. Regular oral and denture hygiene with regular 
oral examination can prevent most cases of oral candidiasis (Akpan and Morgan, 2002).  In 
addition topical antifungal agents can be used.  
 
1.2.3 Oral candidiasis in cancer patients 
High percentages of cancer patients on cancer therapy carry Candida in their oral cavities and 
are at a great risk of developing oral candidiasis. In these patients with all types of cancers, the 
prevalence of oral colonization with Candida was 48% before treatment and during treatment 
increased to 72% (Lalla et al., 2010). This increased colonization affects the risk of oral infection 
development. 
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In patients undergoing head and neck radiotherapy, Candida colonization tends to increase 
throughout the course of treatment and remain increased if xerostomia occurs (Hancock et al., 
2003). Prevalence of oral candidiasis is highest in patients with head and neck cancers in 
comparison to patients with solid tumors and haematological malignancy (Schelenz et al., 2011). 
Up to 73% of patients with head and neck cancers carry Candida in their oral cavities (Redding 
et al., 1999). Although Candida albicans is mostly carried by these patients, other Candida 
species such as C. tropicalis, C. glabrata, C. krusei and C. kefyr are also found (Paula et al., 
1990).  
 
1.2.4 Cancer patients with oral prostheses 
Oral cavity is part of the upper aerodigestive tract that begins at the lips and ends at the anterior 
surface of the facial arch. Primary tumours of the oral cavity may arise from epithelium, minor 
salivary glands, tonsils, tongue or submucous tissues. Tumours of dental origin, bone tumours 
and tumours of neurovascular origin are common. The tongue, alveolus, gingivo-buccal sulcus, 
buccal mucosa are some of the common subsites of carcinoma. Oral cancer is traditionally 
defined as squamous cell carcinoma of the lip, oral cavity and oropharynx (Carnelio and 
Rodrigues, 2004). It is estimated that thousands of people die daily due to oropharyngeal 
malignancy. In addition, oral cancer is frequently associated with the development of multiple 
primary tumors. The primary tumors develop independently in the upper aerodigestive tract as a 
result of chronic exposure of the lining mucosal epithelium to carcinogens, and the theory is 
known as “field cancerization”. Oral cancer patients, who live five years after their initial 
16 
 
primary disease are diagnosed and treated, have up to a 35% chance of developing at least one 
new primary tumor during that time (Lingen et al., 2008, Parkin et al., 2001). 
 
These patients are significantly challenged with both intra- and post-therapy oral complications 
resulting from radiation therapy. These complications can be divided into two groups on the 
basis of the usual time of their occurrence: 1) Acute complications occurring during therapy, 
which include oropharyngeal mucositis, sialadenitis and xerostomia, infections (primarily 
candidiasis), taste dysfunction. 2) Chronic complications which include mucosal fibrosis and 
atrophy, decreased saliva secretion and xerostomia, accelerated dental caries related to 
compromised saliva secretion, infections (primarily candidiasis), tissue necrosis, taste 
dysfunction, muscular and cutaneous fibrosis and dysphagia (National Cancer Institute, 2012). 
These adverse effects require additional palliative treatment to alleviate these troublesome 
symptoms (Weinberg et al., 2011). Therefore, cancer of the head and neck region can profoundly 
affect the quality of life of patients (Guttal et al., 2010). 
  
Approximately 300 000 cases worldwide were diagnosed with oral cancers in 2003, making it 
the sixth most common malignancy in the world (Petersen PE, 2009). They are the most 
common cancers constituting almost fifty percent (50%) of all cancers diagnosed in males. The 
incidence is 3.8 to 11 per 100,000 population but the rates differ from region to region. Oral 
cancer predominantly affects men (Carnelio and Rodrigues, 2004, Petersen, 2009). A study by 
Fleming et al. (1982) showed that among South African Blacks, a high male: female ratio (7:1) is 
related to the differences in tobacco usage between the sexes. Oral cancer, like most other 
cancers, affects older individuals mostly over the age of forty (Carnelio and Rodrigues, 2004). 
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Malignant tumors of the maxilla and hard palate account for 1-5% of malignant neoplasms of the 
oral cavity. Majority of these lesions are squamous cell carcinomas. Most of these cancers are 
diagnosed late when they have affected the underlying bone. The procedures of choice for 
removal are alveolectomy, palatectomy, maxillectomy, which may require total or partial 
surgical reconstruction of the defect. This may be carried out using a wide range of 
microvascularized flaps which are supported by a single or multiple obturator prostheses (Tirelli 
et al., 2010). The maxillofacial prosthodontist, as a member of the surgical team, is able to aid in 
the recovery and rehabilitation of these patient by fabricating and placing a surgical obturator 
and prostheses (Figure 1.3). The prostheses support soft tissues after surgery and minimize scar 
contracture and disfigurement thereby having a positive effect on the patients’ psychology and 
functions (Shambharkar et al., 2011). 
 
 
  
   
 
 
 
        
 
 
 
Figure 1.3 Occclusal view of obturator Prosthesis. [Source: Ramaraju et al., 2010] 
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Rehabilitation via palatal obturators aims to restore the separation between the oral and nasal 
cavities which enable the patient to swallow, provide mastication, and mandibular support, 
support the soft facial tissues, re-establish speech and restore a smile (Tirelli et al., 2010). The 
majority of patients undergoing prosthetic treatment demonstrate the presence of yeast-like fungi 
on their oral mucosa. Patients treated for maxillary tumours reveal increased incidence of fungi. 
Post-surgical cavity inflammation due to Candida species commonly occurs in patients with 
removed maxillary tumour in whom the post-surgical wound is closed by means of an obturator 
(Więckiewicz et al., 2002). 
 
The development of the pathological process is associated with the adherence of pathogenic 
fungi to tissues in contact with the prosthesis obturator. This effects the development of the fungi 
on the mucous membrane as well as the prosthesis. The cells of the fungus adhere permanently 
to the mucosal cells of the host because they have adhesins on their surface corresponding to the 
receptors that are present on the host’s cells. The binding force depends on the number of 
receptors and the mutual affinity of the receptors and adhesins (Więckiewicz et al., 2002). 
 
Hyposalivation as well as the oral prostheses increases the risk of colonization and infection. A 
number of constituents of saliva provide mucosal defense. Long-term dry mouth (sicca 
syndrome) can also contribute to persistent increased risk of OPC (Bensadoun et al., 2011). 
Salivary secretion is greatly suppressed by cancer therapy causing Candida cell overgrowth 
which gives rise to itching and burning pain of the oral mucosa (Umazume et al., 1995). Recent 
data on the frequency of OPC in patients with cancer is limited, and the prevalence of OPC is 
probably underestimated. It was reported as 5-60% in patients with solid tumors and 20-80% in 
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autologous bone marrow transplantation (Bensadoun et al., 2011).  There is limited information 
available on the status of Candida carriage and virulence in patients with oral prostheses.  
 
1.3 Pathogenicity of C. albicans 
Pathogenesis is the ability of a microorganism to infect the host and produce disease resulting 
from the interaction of pathogen with host. Pathogenicity of the fungus (Candida) is complex, 
involving both yeast and host factors and depends on its ability to adapt to the tissue environment 
and to withstand the lytic activity of the host’s defenses. Several factors including genes or gene 
products for example, enzyme molecules are known as virulence factors that are involved in this 
relationship and produce superficial to invasive infections in humans (Khan et al., 2010).  
 
To produce disease in a patient, a fungus must actively invade tissues. Many human fungal 
pathogens are dimorphic, that is capable of reversible transitions between yeast and hyphal 
forms. The morphogenetic transition between these forms is often stimulated by growth in the 
host and correlated with host invasion (Khan et al., 2010, Molero et al., 1998). Determinants of 
pathogenicity are called virulence factors. Pathogenic microbes often possess a number of 
virulence factors and mechanisms. These factors determine whether the host lives or dies during 
host-microbe interactions (Khan et al., 2010).  
 
The virulence factor can be assessed by comparing biological response in fungi with or without 
the factor. The most convincing evidence for a factor to be considered as a virulence determinant 
is the simultaneous loss of the factor and loss of virulence, and the regaining of virulence when 
the factor is restored. Virulence factors must help the pathogen to grow at elevated temperatures, 
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facilitated adherence, penetration and dissemination, or assist in resistance against innate 
immune defenses. The ability of a fungus to grow at 37°C and physiological pH is a virulence 
factor for fungi that invade deep tissue, and the transition to parasitic form is essential for the 
pathogenicity of dimorphic fungi (Khan et al., 2010).  
 
The pH of the oral cavity also plays a role in the pathogenicity. According to Salerno et al., 
(2011), low levels of pH can favour the adhesion and the proliferation of Candida yeast. In fact, 
a pH of 3 is optimal not only for the adhesion of the yeasts, but also for the enzymatic activity of 
the proteinases that, together with the lipases, are the most important factors of virulence of 
Candida because of their cytotoxic and cytolytic effects. Moreover, high levels of carbohydrates 
present in the saliva can act as an additional nourishing source for the Candida yeasts. By 
metabolizing these sugars, they produce acid metabolic products and maintain a low 
environmental pH (Salerno et al., 2011). 
 
Candida albicans possesses many virulence properties, such as the ability to adhere to host 
tissues and prostheses (eg. dentures), phenotypic switching, the ability to form germ tube for 
tissue invasion and the ability to produce a range of hydrolytic enzymes such as proteinases and 
phospholipases that hydrolyse peptide bonds and phospholipids respectively and cause tissue 
invasion and damage (Khan et al., 2010 and Samarananyake, 2002). The switching mechanisms 
of Candida may assist in pathogenesis by permitting the yeast to escape the action of antifungals, 
elude the immune system by altering surface antigens and maximize the attachment, colonization 
and invasion of a variety of body surfaces (Calderone and Fonzi, 2001). The virulence factors 
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required by Candida to cause infections may vary, shown in Figure 1.4, depending on the type of 
infection, the stage of infection, the site of infection and the nature of the host response (Naglik 
et al., 2003). 
 
A number of factors contribute to the pathological state of transition from commensal yeast to 
pathogenic parasite in patients with malignancies. Cancer chemotherapy may lead to damage to 
the mucosal barrier that may result in epithelial atrophy and mucosal ulceration, which may be 
associated with increased adherence and invasion of Candida (Bensadoun et al., 2011). 
 
Figure 1.4 Schematic diagram illustrating virulence attributes to C. albicans pathogenicity. 
[Source: Naglik et al., 2003] 
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1.3.1 Germ tube formation 
Germ tubes are the initial projections observed when C. albicans switches from yeast form to 
hyphal growth. Growth is polarized in C. albicans hypha, with continuous apical growth 
throughout the cell cycle and parallel cell walls at the septal junctions. The principal determinant 
in the development of disease is the ability of C. albicans to switch between yeast and hyphal 
forms rather than the individual morphologies (Nadeem et al., 2013). Germ tubes, that are short 
hyphal elements, are important in the penetration of adherent organism to the host epithelium. 
Researches have established that hyphal form is more virulent than yeast form. This phenomenon 
can be stimulated in the laboratory environment using blood serum. 
 
The Germ Tube Test (GTT) is the most generally accepted and economical method used in the 
clinical laboratories for the identification of yeasts. Approximately 75% of the yeasts recovered 
from clinical specimens are C. albicans and the GTT usually provides a definitive identification 
of this organism within 3 hours. The GTT is specific for the identification of C. albicans with the 
exception of an occasional isolate of C. tropicalis that may rarely produce germ tubes whereas C. 
dubliniensis is also positive (Forbes et al., 1998). Candida albicans produce germ tube which is 
an initial stage of hyphae formation in the presence of host. In GTT, C. albicans is incubated in 
the presence of either horse serum or fetal calf serum which stimulates germ tube formation 
which is detected microscopically (Figure 1.6). 
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Figure 1.5 Candida albicans with germ tube after incubation at 37ºC.  
Arrows shows germ tube formation. [Source: Photographed by the investigator] 
 
 
 
 
1.3.2 Adherence  
The ability of a Candida to invade different environments in the host organism is a result of great 
flexibility and adaptability of the fungi. This phenomenon is in part due to the presence of 
different adhesins connected with cell surface, which facilitate the first stage of infection called 
adherence (Karkowska-Kuleta et al., 2009). The ability of Candida spp. to adhere to an oral 
surface is crucial in colonization, persistence within the host and pathogenesis. Without 
attachment, the growth rate of C. albicans (about 1.5 hours per generation in a rich growth 
medium) is insufficient to maintain carriage in the mouth or gastro-intestinal tract. If yeast is 
unable to attach to a surface it will be removed by the mechanical washing action of saliva, 
swallowed, and destroyed by gastric acid. Therefore, yeast cells need to adhere to the surface of 
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mucous membranes. Also, the growth conditions in the oral cavity are not suitable unless the 
yeast cells adhere. Adherence allows yeast cells the chance to proliferate and colonize the host, 
with or without signs or symptoms of infection (Calderone and Fonzi, 2001). The balance 
between colonization and overt infection may be tipped toward infection in compromised 
individuals by changes in the expression of adherence ligands and receptors. Candida cells 
adhere to several host cell types, including epithelia (Figure 1.6), endothelial and phagocytic 
cells (Cannon et al., 1995). 
 
 
Figure 1.6 Light microscope image showing the adherence of yeast cells (black) to an 
epithelial cell (stained pink). [Source: Photographed by the investigator] 
  
It is well-known that C. albicans adhesion to mucosa cells is enhanced by several factors such as 
germ tube production, phospholipase, protease, other extracellular enzymatic activities, 
carbohydrates, pH and temperature. Once this organism is established on the tissue surface, it 
produces germ tube or hyphae which will penetrate the host tissues for invasion. The ability of 
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hyphae formation can vary from strain to strain; therefore, virulence property can be determined 
by monitoring hyphae formation (Vidotto et al., 2003, Akpan and Morgan, 2002, Molero et al., 
1998). 
 
Strains of C. albicans with increased adherence ability are more pathogenic than strains that 
adhere less. There is a positive correlation between adherence and pathogenicity. For example C. 
albicans isolated from the oral cavities of HIV positive patients has increased adherence ability 
and therefore considered to have increased virulence (Sweet et al., 1995). Adherence occurs 
between moieties of the C. albicans cell wall and host surfaces (Cannon and Chaffin, 1999). 
Candida albicans presents adhesins on the cell wall surface, which are responsible for adhesion 
to epithelial and endothelial cells, serum proteins and extracellular matrix proteins (Chaffin et al., 
1998, Karkowska-Kuleta et al., 2009).  
 
Many cell-surface adhesins have been identified and characterized biochemically. These surface 
proteins may play a role in the adherence of C. albicans to extracellular matrix proteins and host 
cell surfaces. Genetic and molecular biology approaches have allowed for the investigation of 
adhesin function by isolating and expressing these genes in heterologous hosts (Cannon and 
Chaffin, 1999). One gene family of C. albicans called the agglutinin-like sequence (ALS) has 
been studied extensively since it encodes for adhesins that were observed to play a role in 
adherence. Members of ALS family are related to Saccharomyces cerevisiae agglutinin genes 
that enable cell-cell interactions during mating of haploid cells (Cannon and Chaffin, 1999, 
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Calderone and Fonzi, 2001). The gene family includes at least nine genes and has also been 
found in other Candida species such as C. dubliniensis and C. tropicalis. The proteins encoded 
by these genes have been found on the surface of C. albicans cells in the host environment and 
therefore these proteins play an important role in host-pathogen interactions (Hoyer et al., 2001).  
 
The yeast/host cell interaction is also affected by external factors such as drug treatment. 
Antibiotic treatment can cause C. albicans overgrowth in the oral cavity by eliminating 
competing microorganisms and exposing additional sites suitable for colonization. Antifungals, 
however, can reduce the adherence of C. albicans in vitro. This effect may enhance drug 
efficacy. Pre-treatment of prostheses or mucosae may also help to prevent infection by reducing 
yeast adherence (Cannon et al., 1995). 
 
Adherence of C. albicans to plastic medical devices (medical implants, prostheses and catheters) 
allows the organism to propagate and establish biofilms to release microorganisms from these 
biofilms which contributes to or initiates acute disseminated nosocomial infections. Several 
components of the microfibrillar surface layer of C. albicans are implicated in plastic binding 
and plastic adherence and appear to be mediated by cell surface hydrophobicity (CSH) through 
hydrophobic bonds between the plastic surface and the peptide moieties of the mannoproteins. 
These mannoproteins may play other significant roles in cell physiology rather than specifically 
bind to plastic surfaces. Salivary proteins, adsorbed to plastic material of dental or voice 
prostheses may also help colonization by fungal cells (Mishra et al., 2007).  
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1.3.3 Hydrolytic enzymes 
Among the factors known to contribute to the pathogenicity of yeast, hydrolytic enzymes play a 
significant role, possibly being harmful to the host tissues when they are liberated by the fungi. 
These enzymes play a role in nutrition but also in tissue damage, dissemination within the human 
organism, iron acquisition and overcoming the host immune system, and therefore strongly 
contribute to fungal pathogenicity (Karkwoska-Kuleta et al., 2009). Candida albicans produces a 
range of hydrolytic enzymes that have various roles in the infection process. The two enzymes 
that have received the most attention are proteinases and phospholipases and are important 
virulence determinants (Haynes, 2001, Abaci, 2011).  
 
Proteinases may act on the epithelial tissues and enable the fungal cells to adhere and hence 
penetrate (Kwon-Chung et al., 1985). These enzymes may also be involved in counteracting the 
host immune response because it is able to resist phagocytosis and intracellular killing 
(MacDonald and Odds, 1983). Secretion of proteinases by pathogens is mandatory in order to 
degrade the tissue barrier and obtain nutrition at the infection site. The extracellular proteolytic 
activity of C. albicans is due to aspartyl proteinase enzymes that constitute a family of enzymes 
SAPs, whose expression depends on both the yeast strain and the environment. Several 
observations suggest a major role for SAP proteins in the pathogenicity of candidiasis: a) SAPs 
are secreted by pathogenic Candida spp. in vivo during infection and there is a correlation 
between virulence and the level of proteinase production in both clinical isolates and laboratory 
strains of C. albicans, b) the enzymes are able to degrade a number of important defensive host 
proteins such as immunoglobulins and complement and c) genetically engineered strains with 
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disruptions in SAP genes were less virulent in an animal model of disseminated candidiasis. 
Therefore, proteinase production appears to enhance the ability of the fungal cells to colonize 
and penetrate host tissues and to evade the host immune system (Mishra et al., 2007).  
 
Secreted aspartyl proteinases (SAPs) from Candida hydrolyze many proteins such as albumin, 
hemoglobin, keratin, collagen, laminin, fibronectin, mucin, salivary lactoferrin, interleukin 1β, 
cystatin A and Immunoglobulin. It has been reported that the production of SAPs also correlates 
with hyphal formation, adherence and phenotypic switching which highlights the complex role 
played by SAPs in the pathogenicity of C. albicans (Khan et al., 2010). These are extracellular 
enzymes and therefore can be detected in a laboratory environment. Growth of C. albicans on 
the culture media containing serum albumin, as a protein source, can show proteinase production 
around the colonies. This agar plate is opaque white due to the protein which can be stained with 
coomassie blue. Proteinase producing colonies would show colourless to light blue ring around 
the colonies.   
 
Phospholipases activities are considered as putative virulence factors since they are associated 
with host cell penetration, adhesion to epithelial cells, invasion of epithelial cells, and interaction 
with host signal transduction pathways (Schaller et al., 1999, Mishra et al., 2007). These 
enzymes hydrolyze ester linkages of glycophospholipids and hence impart tissue invasiveness to 
Candida cells (Khan et al., 2010). Experiments involving the disruption of a gene that encodes 
for a phospholipase has shown a decrease in virulence and a reduced ability of C. albicans to 
penetrate host cells. This suggests that phospholipases play a role in causing damage to host cell 
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membranes. Furthermore C. albicans cells isolated from blood have higher extracellular 
phospholipase activity than commensal strain (Leidich et al., 1998, Khan et al., 2010). 
Phospholipases can be detected in a laboratory environment on agar plates containing Egg Yolk. 
Breakdown of phospholipids around the colonies creates opaque measurable zone.  
Virulence of Candida depends on the production of these virulence factors. The production of 
these virulence determinants and the number Candida present in the host depends on the host 
immunity (Khan et al., 2010). During commensal state, the number of Candida and their 
expression of virulence factors in denture wearers and cancer patients with prostheses have not 
been studied.  
  
1.4 AIM 
The aim of this study was to compare the pathogenic characteristics of C. albicans isolated from 
the oral cavities of normal subjects, denture-wearers and cancer patients wearing oral prostheses. 
 
1.5   OBJECTIVES 
 To isolate and identify Candida species from the oral cavities of healthy subjects, 
denture-wearers and cancer patients wearing oral prostheses. 
 To determine the quantity of C. albicans carried in the oral cavity of the three groups. 
 To study pathogenic characteristics such as production of germ tube, hydrolytic enzymes, 
and the adherence ability of C. albicans isolated from the three groups. 
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CHAPTER 2 
METHODS 
2.1 Subject selection 
A total number of 102 subjects were screened for Candida carriage during the period of 2011 to 
2012. The HIV status of all the subjects was not known. The control group consisted of 48 
healthy subjects who are staff members at Wits, Oral Microbiology laboratory and National 
Health Laboratories Services (NHLS) in Charlotte Maxeke Johannesburg Academic Hospital 
(CMJAH). None of these subjects wore dentures or had systemic illness. The denture wearing 
group consisted of 35 patients with complete dentures having no signs and/or symptoms of 
denture related stomatitis. They were either attending clinics at Wits Oral and Dental Hospital or 
living in Golden Acres, Sandringham Retirement Home. The third group consisted of 19 patients 
with oral cancer and oral prostheses attending Wits Oral and Dental Hospital.  
 
All the subjects agreed to participate in the study and signed consent forms. Ethical clearance 
was obtained from the Human Research Ethics Committee (Medical), University of 
Witwatersrand, Johannesburg (Appendix 6.2) and the clearance number is M110320.  
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2.2 Microbiological analysis 
2.2.1 Sample collection and processing 
Oral rinse samples were collected using the technique described by Samaranayake et al. (1986). 
Each subject was requested to rinse the mouth for 60 seconds with 10 milliliter of sterile distilled 
water and expectorate the rinse into a sterile universal bottle. Both denture wearers and cancer 
patients retained their prostheses during sample collection. Oral rinse samples were diluted to 
1:10 and 1:100, and 100 µl of the diluted samples were spread on CHROMagar Candida agar 
(CHROMagar, Paris, France) and incubated aerobically at 37°C for 48 hours. The number of 
colonies on the CHROMagar plates was counted and the oral yeast carriage rate was expressed 
as colony forming units per milliliter (cfu/ml) of oral rinse. CHROMagar Candida allowed the 
identification of Candida species through the growth of yeast colonies and the colour of the 
colonies (Figure 2.1). Presumptive Candida albicans colonies appeared green whereas C. 
tropicalis blue and C. glabrata white. Single yeast colonies with different colours were 
subcultured on Sabouraud dextrose agar (SAB) until pure cultures were obtained and were 
further tested for the definite identification.  
Note: List of media, reagents and the preparation procedures are given in Appendix 6.1. 
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Figure 2.1 Colonies of different species of Candida on CHROMagar Candida medium. (A) 
Dark pink colonies of C. glabrata (B) Pale colonies of C. parapsilosis (C) Green colonies of C. 
albicans (D) Colonies of a Geotrichumn sp. (E) Colonies of C. tropicalis (F) colonies of 
Trichosporon sp.  [Source: Odds and Bernaerts, 1994]  
 
 
2.2.2 Identification 
An API 20C AUX kit (Biomerieux, France) was used to confirm presumptive identification of 
all the Candida isolates. Pure cultures of each isolate was subcultured on SAB plates and 
suspended in 2ml sterile distilled H2O equivalent to 0.5 McFarland turbidity standards. A 100 µl 
aliquot of this preparation was inoculated into the corresponding C medium tube that was 
provided with the kit. The inoculated C medium was transferred into the corresponding API 20C 
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strips. Each strip was incubated at 30°C for 48-72 hours. The strips were read for growth and 
cupules with turbidity significantly greater than of the negative control cupule were considered 
positive.  
 
Figure 2.2 API 20C AUX identification system for C. albicans. [Source: photographed by 
the investigator] 
 
Twenty strains of C. albicans were selected from normal subjects and denture wearers groups, 
and 14 from cancer patients with prostheses group. The virulence factors such as ability to 
adhere to the oral epithelial cells and form germ tube, and the production of proteinase and 
phospholipase of these strains were examined.  
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2.3 Germ tube formation 
Germ tube formation was investigated using a technique described by Mackenzie (1962). A 0.5 
ml of sterile horse serum was inoculated with a loopful of culture of C. albicans. Controls were 
set up using a known C. albicans (known to produce germ tube) as positive control and C. 
parapsilosis (do not produce germ tube) as negative control. The mixture was incubated for 2½ 
hours, aerobically at 37°C. A drop of suspension was placed on a clean microscopic slide using a 
capillary tube, covered with a coverslip and examined microscopically using the X10 and X40 
objective lenses for the production of germ tubes. Cells that produced a germ tube at least twice 
the length of the cell were considered. Fifty yeast cells of each isolate were examined for germ 
tube formation and percentage was calculated. 
 
2.4 Adherence assay 
Adherence assays were performed using technique described by Ghannoum and Elteen (1986) 
with minor modification. The C. albicans cultures were inoculated into Sabouraud dextrose broth 
(Oxoid, Hampshire, England) and incubated at 37°C for 24 hours while shaking at 60rpm. Yeast 
cells were harvested by centrifugation (5000rpm, 15 minutes), washed three times with sterile 
distilled H2O by repeated centrifugation, resuspended in 2 ml sterile distilled H2O and adjusted 
to the concentration of 10
5
 cells/ml. Buccal epithelial cells (BECs) were collected from the 
mouth of healthy (non-carrier of Candida) volunteer by gently rubbing the oral mucosal surface 
of the cheek with a sterile swab. The swab was then immersed in 4 ml sterile distilled H2O. The 
cell suspension was centrifuged (5000rpm for 15 minutes), then the cell pellet was washed three 
times and resuspended into 2 ml sterile distilled water. Two milliliters of the cells and 2 ml of 
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yeast cell suspensions were mixed in sterile screw-capped bottle, incubated for 3 hours at 37
o
C 
while shaking at 60rpm. The mixture was filtered through a nylon mesh with 20 µm pores 
(Nucleopore GMBh, Germany) to remove non-adherent yeast cells. The BECs on the filter were 
washed twice with 5 ml sterile distilled H2O and finally suspended in 2ml of sterile distilled 
H2O. A drop of this suspension was mounted on a glass slide, air-dried, heat fixed and Gram 
stained. Adherence was determined microscopically by counting the number of adherent yeast 
cells per hundred BECs (Figure 2.3). 
 
Figure 2.3 C. albicans cells (black arrows) adherent to the epithelial cell (green arrow) 
[Source: Photographed by the investigator] 
 
2.5 Phospholipase Activity 
 Phospholipase production was detected using the egg yolk media (EYM) as described by Price 
et al. (1982). It contained 13g Sabouraud agar, 11.7g NaCl, 0.11g CaCl2 and 20ml sterile egg 
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yolk emulsion. A suspension of fresh C. albicans culture containing 10
7 
cfu/ml cells was 
prepared and 20µl was inoculated onto the four blank paper discs placed on the egg yolk agar 
plates, incubated aerobically for four days at 37°C. The diameters of colony (A) and the colony 
plus precipitation zone (B) were measured. The phospholipase activity of the isolates was 
considered positive when a precipitation zone was visible around the growth (Figure 2.4). The 
phospholipase activity (Pz) was expressed as Pz = A/B (in mm). The phospholipase activity of 
each isolate was recorded as the average of the four measurements. Pz of 1 indicated there was 
no phospholipase activity. Lower values indicated higher production of phospholipase. 
 
    
Figure 2.4 Phospholipase production by C. albicans on Egg Yolk media.  
[Source: Photographed by the investigator] 
 
 
 
Paper disc 
Growth of organism 
Phospholipase production 
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2.6 Proteinase Activity  
Proteinase production was detected using the modified method described by Aoki et al., (1990). 
A suspension of fresh C. albicans culture containing 10
7 
cfu/ml cells was prepared and 20µl was 
inoculated onto the four sterile paper discs placed on the Yeast Carbon Base- Bovine Serum 
Albumin (YCB-BSA) medium plates. The medium contained 1.5% Columbia agar, 1.17% Yeast 
Carbon Base powder, 0.2% Bovine Serum Albumin (BSA) and 0.2% glucose. The plates were 
incubated aerobically at 37°C for fourteen days. The diameter of the colonies was measured and 
recorded. Plates were then stained with 0.5% Coomasie brilliant blue R250 (Pierce 
Biotechnology) for 20 min at room temperature and destained three times for 20 min at 37
o
C 
using a destaining solution (Appendix 6.1) and once with distilled water. The diameter of the 
colonies was measured before staining and the diameter of the clearing zones were measured 
after staining (Figure 2.5). Proteinase activity (Pr) was expressed as the ratio of diameter of 
colony to total diameter of colony plus clearing zone (in mm). The Pr value was taken as the 
average of the four measurements. When the Pr equaled 1, no proteinase activity was detected in 
the strain. Thus, a low Pr value indicated high enzyme production.  
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Figure 2.5 Proteinase production by C. albicans.  
[Source: Photographed by the investigator]  
 
2.7 Statistical analysis of data 
Scheffe test for pairwise comparison and chi square test was used to compare the Candida counts 
in these study groups. 
 
The results of the virulence factors i.e. germ tube formation, adherence, proteinase and 
phospholipase production by the strains of C. albicans isolated from the 3 groups were compared 
using a Kruskal-Wallis test for pairwise comparison and a chi square test. 
Note: Statistical analysis of results is given in Appendix 6.3. 
 
 
 
 
 
 
Proteinase production 
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CHAPTER 3 
 RESULTS 
3.1 Isolation and identification of Candida species  
3.1.1 Normal healthy subjects 
Forty nine subjects were screened for the Candida carriage, shown in Table 3.1. Their ages 
ranged from 21-70 years with the mean of 34 years and consisted of 9 males and 40 females. 
Twenty one subjects were colonized with C. albicans and the mean Candida count in the oral 
cavity rinse was 326 cfu/ml.   
Table 3.1 Candida carriage in Normal healthy subjects  
Subject no. Age/gender Count cfu/ml Identification 
N1  56/M 0 - 
N2  24/F 20 C. albicans 
N3 35/F 30 C. albicans 
N4  30/M 0 - 
N5  36/F 0 - 
N6  25/F 0 - 
N7  38/F 0 - 
N8  51/M 945 C. albicans 
N9  25/F 20 C. albicans 
N10 30/M 0 - 
N11 24/M 80 C. albicans 
N12 28/M 0 - 
N13 30/M 10 C. albicans 
N14 28/F 0 - 
N15 24/M 1058 C. albicans 
N16 27/F 60 C. albicans 
N17 28/F 0 - 
N18 29/F 0 - 
N19 29/F 0 - 
N20 35/M 0 - 
N21 26/F 0 - 
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Table 3.1 Candida carriage in Normal healthy subjects (continues) 
Subject no. Age/gender Count cfu/ml Identification 
N22 26/F 2146 C. albicans 
N23 25/F 0 - 
N24 25/F 0 - 
N25 21/F 550 C. albicans 
N26 23/F 0 - 
N27 23/F 0 - 
N28 28/F 0 - 
N29 25/F 0 - 
N30 39/F 240 C. albicans 
N31 38/F 70 C. albicans 
N32 41/F 0 - 
N33 34/F 80 C. albicans 
N34 25/F 0 - 
N35 35/F 10 C. albicans 
N36 29/F 0 - 
N37 29/F 0 - 
N38 23/F 0 - 
N39 30/F 0 - 
N40 55/F 150 C. albicans 
N41 46/F 20 C. albicans 
N42 40/F 0 - 
N43 58/F 60 C. albicans 
N44 58/F 1108 C. albicans 
N45 40/F 100 C. albicans 
N46 35/F 0 - 
N47 25/F 0 - 
N48 60/F 40 C. albicans 
N49 70/F 50 C. albicans 
 
Mean age 34 
M9+ F40 
Mean count 
326 cfu/ml/ 
coloniser 21 - C. albicans 
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3.1.2 Denture wearers 
Thirty five denture wearers were screened for the Candida carriage, shown in Table 3.2. The 
mean age of this study group was 75 years with 17 males and 18 females. Twenty individuals 
were colonized with 20 C. albicans and the mean of Candida count was 9878 cfu/ml. 
Table 3.2 Candida carriage in Denture wearers  
Subject no. Age/gender 
Count 
cfu/ml Identification 
D1 70/F 350 C. albicans 
D2 
  60/F 
2106 C. glabrata 
49300 C. dubliniensis 
D3 
  88/M 
410 C. albicans 
240 C. glabrata 
D4 
  86/F 
76300 C. albicans 
3520 C. famata 
D5 
  72/M 
8000 C. albicans 
1254 C. glabrata 
D6 75/M 0 - 
D7 80/M 475 C. albicans 
D8 68/M 0 - 
D9 72/M 660 C. albicans 
D10 65/M 0 - 
D11 
  82/M 
3700 C. glabrata 
10 C. albicans 
D12 65/M 0 - 
D13 69/F 0 - 
D14 73/M 0 - 
D15 74/F 100 C. parapsilosis 
D16 86/F 2200 C. albicans 
D17 
  80/F 
395 C. guilliermondii 
265 C. tropicalis 
D18 67/F 75200 C. glabrata 
D19 78/F 0 - 
D20 75/M 0 - 
D21 69/F 0 - 
D22 F 642 C. glabrata 
D23 M 380 C. glabrata 
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Table 3.2 Candida carriage in Denture wearers (continues) 
Subject no. Age/gender 
Count 
cfu/ml Identification 
D24 71/M 520 C. albicans 
D25 70/M 480 C. albicans 
D26 
  M 
48950 C. albicans 
1460 Cryptococcus neoformans 
D27 
  
  M 
8000 C. albicans 
7400 C. glabrata 
2050 C. famata 
D28 
  
  F 
63400 C. albicans 
4650 C. tropicalis 
D29 
  F 
35000 C. albicans 
20 Cryptococcus neoformans 
D30 
  
  M 
8042 C. albicans 
640 Trichosporon mucoides 
420 Kodamaea ohmeri 
D31 
  81/F 
2690 C. albicans 
33700 C. glabrata 
D32 
  65/F 
15110 C. albicans 
21650 C. glabrata 
D33 
  90/F 
50 C. albicans 
264 C. glabrata 
D34 
  86/F 
3840 C. albicans 
1500 C. glabrata 
D35 
  88/F 
4475 C. albicans 
550 Cryptococcus  neoformans 
350 C. glabrata 
  
Mean age 75 
Age unknown 7 
M17/F18 
Mean count 
9878 cfu/ml/ 
coloniser 20- C. albicans 
 
3.1.3 Cancer patients with prostheses 
Nineteen oral cancer patients with prostheses were screened for the Candida carriage, shown in 
Table 3.3. The mean age of this study group was 70 years with 6 males and 13 females. Fourteen 
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patients were colonized with C. albicans and the mean Candida count in the oral cavity rinse 
was 13977 cfu/ml. 
Table 3.3 Candida carriage in Cancer patients with oral prostheses  
Subject no. Age/gender Count cfu/ml  ID 
 
  
 C1 83/M 
73000 C. albicans 
6243 C. glabrata 
96000 S. cerevisiae 
 
 C2 F 
1250 C. krusei 
864 C. tropicalis 
C3 76/M 110 C. albicans 
C4 57/F 115 C. albicans 
C5 51/F 0 - 
 
 C6 63/F 
7600 C. albicans 
48300 C. glabrata 
 
  
 C7 M 
7075 C. albicans 
125 C. tropicalis 
70 C. glabrata 
 
 C8 73/F 
59425 C. albicans 
8855 C. glabrata 
C9 84/M 
21005 C. albicans 
12550 C. glabrata 
C10 88/M 
2864 C. albicans 
1248 C. glabrata 
C11 67/M 3600 C. albicans 
C12 75/F 
2400 C. albicans 
100 C. glabrata 
C13 64/F 0 - 
C14 66/F 10 C. albicans 
C15 77/F 345 C. albicans 
C16 72/F 45200 C. albicans 
C17 68/F 1990 C. albicans 
C18 
55/F 3500 C. glabrata 
 1510       C. krusei 
C19 71/F 0 - 
 
Mean age 70 
Age unknown 1 
M6+ F13 
Mean count 
13977 cfu/ml/ 
coloniser 14 - C. albicans 
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3.1.4 Candida carriage 
The carriage of Candida species in the normal subjects, denture wearers and cancer patients with 
prostheses was 42.86%, 74.29% and 84.21% respectively (Table 3.4). All though the groups 
were not matched for the risk factors, the carriage of Candida species between the normal 
subjects and denture wearers and cancer patients with prostheses were significantly different 
(p<0.01).  
 
Table 3.4 Carriage of Candida species in the three groups  
 
Study Group 
No. of subjects/ 
patients 
screened 
No. of 
subjects/ 
patients with 
Candida 
species 
 
Prevalence (%) 
of Candida 
species 
Normal subjects 49 21 42.86*, ** 
Denture wearers 35 26 74.29* 
Cancer patients 
with prostheses 
19 16 84.21** 
*: p<0.01, **: p<0.01 
 
3.1.5 Multiple Candida colonization  
Several Candida species were isolated from the denture wearers and cancer patients with 
prostheses (Table 3.5). Normal subjects yielded only C. albicans strains. In contrast, 28.57% of 
denture wearers carried only one strain of yeast and 45.72% carried multiple yeast strains. In 
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cancer patients with prostheses, 36.84% of the patients carried single yeast strain and 47.37% 
carried multiple strains of yeasts. 
 
Table 3.5 Multiple Candida colonization of the three study groups  
 
Study Group 
No. of patients with no 
Candida spp. 
(%) 
No. of patients with 
single Candida spp. 
(%) 
No. of patients with 
multiple Candida spp. 
(%) 
Normal subjects 
N=49 
28 
(57.14%) 
21 
(42.85%) 
- 
Denture wearers 
N=35 
9 
(25.71%) 
10 
(28.57%) 
16 
(45.72%) 
Cancer patients 
N=19 
3 
(15.79%) 
7 
(36.84%) 
9 
(47.37%) 
 
Table 3.6 shows a higher occurrence of mixed/multiple Candida species characterized in denture 
wearers and cancer patients. Greater variety of yeasts was isolated from the denture wearers than 
the cancer patients. 
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Table 3.6 Various fungi including Candida species isolated from the three study groups  
Isolated 
Candida species 
Normal subjects 
(21 Strains) 
Denture wearers 
(49 Strains) 
Cancer patients 
(29 Strains) 
C. albicans 21 (100%) 23 (46.9%) 15 (78.9%) 
C. glabrata - 13 (26.5%) 8 (27.6%) 
C. tropicalis - 3 (6.1%) 2 (6.9%) 
C. parapsilosis - 1 (2.0%) - 
C. guilliermondii - 1 (2.0%) - 
C. famata - 2 (4.1%) - 
C. dubliniensis - 1 (2.0%) - 
C. krusei - - 2 (6.9%) 
Cryptococcus 
neoformans 
- 3 (6.1%) - 
Kodamaea - 1 (2.0%) - 
S. cerevisiae - - 1 (3.5%) 
Trichosporon spp. - 1 (2.0%) - 
 
 
 
3.1.6 Candida count in the study groups  
The mean±SD Candida counts in the normal subjects, denture wearers and cancer patients were 
326.05±549.4, 18616.5±25967 and 59084.63±176407.7 cfu/ml respectively, shown in Table 3.7. 
The Candida counts were significantly higher in the two study groups than the normal subjects 
(p<0.01). Therefore, the Candida counts were categorized as shown in Table 3.8. The results 
showed that 63% of cancer patients with prostheses carried higher numbers of Candida in their 
oral cavity (>1000 cfu/ml) than the denture wearers (42.86%). 
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Table 3.7 Candida count (Mean ± SD) in the colonized study groups 
 (overall of p<0.01)  
Study group Candida count (cfu/ml) Mean ± SD 
Normal subjects     N=49 326.05 ± 549.4 
Denture wearers     N=35 18616.5 ± 25967 
Cancer patients      N=19 59084.63 ± 176407.7 
 
 
Table 3.8 Candida count (cfu/ml) in the study groups 
 
Study Group 
No. of patients with range of Candida counts (cfu/ml) 
0 (%) 1-100 (%) 101-1000 (%) >1000 (%) 
Normal subjects 
N=49 
 
28 (57.14) 
 
14 (28.57) 
 
7 (14.29) 
 
0 
Denture wearers 
N=35 
 
9 (25.71) 
 
1 (2.86) 
 
10 (28.57) 
 
15 (42.86) 
Cancer patients 
N=19 
 
3 (15.79) 
 
1 (5.26) 
 
3 (15.79) 
 
12 (63.16) 
 
 
3.2 Pathogenic characteristics of C. albicans isolated from the study groups  
The results of the germ tube formation, adherence to epithelial cells, proteinase production and 
phospholipase productions by the strains of C. albicans isolated from the study groups are shown 
in Table 3.9 to Table 3.12. The results of the pathogenic characteristics of the strains isolated 
from the study groups are summarized in Table 3.13. 
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3.2.1 Germ tube formation 
All the strains isolated from study groups produced germ tube (Table 3.9, Table 13 and Figure 
3.5). However, the percentage of C. albicans cells with germ tube varied between the study 
groups. They were 41%, 43% and 57% in the strains isolated from normal subjects, denture 
wearers and cancer patients with prostheses respectively. The overall difference in the germ tube 
formation between the study groups was weakly significant (p=0.03) as shown in Table 3.13. 
 
Table 3.9 Germ tube formation (GTF) by C. albicans isolated from Normal subjects, 
Denture wearers and Cancer patients with prostheses. 
Normal subjects Denture wearers Cancer patients with prostheses 
Subject no 
GTF (% 
yeast cells) Subject no 
GTF (% 
yeast cells) Subject no 
GTF (% yeast 
cells) 
N2 18 D1 42 C1 50 
N3 12 D3 62 C3  62 
N8 24 D4 26 C4  76 
N9 30 D5 46 C6  68 
N11 66 D7 48 C7  52 
N13 68 D9 54 C8  62 
N15 78 D11 60 C9  56 
N16 40 D16 46 C10 64 
N22 12 D24 38 C11 78 
N25 40 D25 44 C12 62 
N30 20 D26 20 C14 28 
N31 42 D27 44 C15 80 
N33 40 D28 48 C16 32 
N35 34 D29 24 C17 28 
N40 52 D30 24 Mean±SD 57.17±17.48 
N41 12 D31 32     
N43 62 D32 76     
N44 58 D33 62     
N45 36 D34 24     
N48 80 D35 44     
Mean±SD 41.2±21.85 Mean±SD 43.2±15.11     
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The results of germ tube formation were further analyzed using Scheffe pair wise comparison.  
Figure 3.1 showed the germ tube formation results which are significantly high (p=0.05) in 
strains isolated from cancer patients (57.17) compared to the normal subjects (41.2). However, 
the significance was marginal and could be due to the wide spread of the results of normal 
subjects. There was no significant difference between the strains isolated from denture wearers 
(43.2) and normal subjects (41.2). In addition, there was no significant difference between the 
results of denture wearers and cancer patients with prostheses. 
 
 
Figure 3.1 Germ tube formation by C. albicans isolated from normal subjects, denture 
wearers and cancer patients with oral prostheses    
 
3.2.2 Adherence assay 
All the strains isolated from the study groups adhered to oral epithelial cells (Table 3.10, Table 
3.13 and Figure 3.5). The mean number of yeast cells isolated from normal subjects, denture 
* 
* 
*: p=0.05 
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wearers and cancer patients with prostheses that were adherent to the epithelial cells were 343.4, 
694.8 and 818.7 respectively. The overall difference in the results was statistically significant 
(p<0.01).  
 
Table 3.10 Adherence of C. albicans isolated from the study groups to oral epithelial cells. 
Normal subjects Denture wearers Cancer patients with prostheses 
Subject 
no  
Adherence  
(yeast/100 
BECs) 
Subject 
no  
Adherence  
(yeast/100 
BECs) 
Subject 
no  
Adherence  
(yeast/100 BECs) 
N2 940 D1 360 C1 652 
N3 156 D3 520 C3  912 
N8 208 D4 692 C4  1102 
N9 584 D5 232 C6  894 
N11 428 D7 152 C7  508 
N13 488 D9 468 C8  878 
N15 520 D11 376 C9  1230 
N16 320 D16 600 C10 968 
N22 148 D24 1312 C11 880 
N25 80 D25 272 C12 640 
N30 268 D26 696 C14 568 
N31 103 D27 1120 C15 1278 
N33 64 D28 742 C16 706 
N35 224 D29 600 C17 246 
N40 116 D30 464 Mean±SD 818.71±286.1 
N41 64 D31 1750     
N43 1103 D32 980     
N44 980 D33 744     
N45 192 D34 956     
N48 364 D35 860     
Mean±SD 343.4±267.6 Mean±SD 694.8±391.44     
 
 
The results of adherence assay were analyzed using Scheffe pair wise comparison.  
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Adherence of strains isolated from denture wearers was significantly higher than strains isolated 
from the normal individuals (p=0.01) as shown in Figure 3.2.  Similarly, adherence of strains 
isolated from cancer patients with prostheses was significantly higher than strains isolated from 
the normal individuals (p<0.01). However, there was no significant difference between the 
results of denture wearers and cancer patients. This may be due to the greater standard deviations 
in the results. 
 
  
Figure 3.2 Adhesion to oral epithelial cells by C. albicans isolated from normal subjects, 
denture wearers and cancer patients with oral prosthesis 
 
3.2.3 Phospholipase production 
The mean of phospholipase production by the strains isolated from normal subjects, denture 
wearers and cancer patients with prostheses was 0.95±0.1, 0.8±0.16 and 1.0±0.18 respectively as 
** 
** 
*: p= 0.01, **: p=<0.01 
* 
* 
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shown in Tables 3.11 and 3.13.  The overall difference in the results was statistically significant 
(p<0.01).  
Phospholipase was produced by 25%, 85% and 57.14% of the C. albicans isolated from normal 
subjects, denture wearers and cancer patients with prostheses respectively (Figure 3.5, Table 
3.14).  
 
Table 3.11 Phospholipase production by C. albicans isolated from Normal subjects, 
Denture wearers and Cancer patients with prostheses. 
Subject no *Pz Subject no *Pz Subject no *Pz 
N2 1 D1 1 C1 1 
N3 1 D3 0.77 C3  0.97 
N8 1 D4 0.73 C4  0.55 
N9 1 D5 0.91 C6  0.58 
N11 0.97 D7 0.81 C7  1 
N13 1 D9 0.96 C8  0.76 
N15 1 D11 0.84 C9  0.74 
N16 0.88 D16 1 C10 0.69 
N22 1 D24 0.82 C11 0.75 
N25 1 D25 0.82 C12 0.97 
N30 1 D26 0.66 C14 1 
N31 1 D27 0.62 C15 1 
N33 1 D28 0.6 C16 1 
N35 1 D29 0.91 C17 1 
N40 0.68 D30 0.73 Mean±SD 1±0.18 
N41 1 D31 0.8     
N43 0.83 D32 0.81     
N44 1 D33 0.69     
N45 1 D34 0.72     
N48 0.69 D35 1     
Mean±SD 0.95±0.1 Mean±SD 0.8±0.16     
*Pz: ratio of the colony diameter and the precipitation zone, therefore lower values indicate greater enzyme 
activity and 1 indicate no enzyme production.   
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The results of phospholipase production were further analyzed using Scheffe pair wise 
comparison.  
 
Phospholipase production of strains isolated from denture wearers was significantly high 
compared to the strains isolated from the normal individuals (p<0.01) as shown in Figure 3.3. 
However, there was no significant difference found between the results of strains isolated from 
normal subjects and cancer patients with prostheses (p>0.05) as well as between denture wearers 
and cancer patients with prostheses groups.   
 
 
Figure 3.3 Phospholipase production by C. albicans isolated from normal subjects, denture 
wearers and cancer patients with oral prostheses Pz: ratio of the colony diameter and the 
precipitation zone, therefore lower values indicate greater enzyme activity and 1 indicate 
no enzyme production.   
* 
* 
*: p=<0.01 
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3.2.4 Proteinase production 
The mean proteinase production by the strains isolated from normal subjects, denture wearers 
and cancer patients with prostheses was 0.92±0.09, 0.81±0.12 and 0.93±0.12 respectively (Table 
3.12, Table 3.13). The overall difference in the results was statistically significant (p=0.02). 
Proteinase was produced by 60%, 80% and 64.29% of the C. albicans isolated from normal 
subjects, denture wearers and cancer patients with prostheses respectively (Figure 3.5, Table 
3.14). 
Table 3.12 Proteinase production by C. albicans isolated from Normal subjects, Denture 
wearers and Cancer patients with prostheses. 
Normal subjects Denture wearers Cancer patients with prostheses 
Subject no *Pr Subject no *Pr Subject no *Pr 
N2 0.84 D1 1 C1 0.87 
N3 0.87 D3 0.92 C3  1 
N8 0.9 D4 0.91 C4  1 
N9 0.93 D5 0.85 C6  1 
N11 0.93 D7 0.91 C7  1 
N13 1 D9 0.75 C8  0.88 
N15 1 D11 0.85 C9  0.57 
N16 1 D16 0.74 C10 0.74 
N22 0.93 D24 0.81 C11 0.99 
N25 0.89 D25 0.89 C12 1 
N30 1 D26 1 C14 0.99 
N31 0.87 D27 0.53 C15 0.99 
N33 0.95 D28 0.57 C16 0.94 
N35 1 D29 0.58 C17 0.98 
N40 0.69 D30 1 Mean±SD 0.93±0.12 
N41 1 D31 0.53     
N43 0.83 D32 1     
N44 1 D33 0.66     
N45 1 D34 0.78     
N48 0.68 D35 0.83     
Mean±SD 0.92±0.098 Mean±SD 0.81±0.12     
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The results of proteinase production were further analyzed using Scheffe pair wise comparison.  
Proteinase production of strains isolated from denture wearers was significantly high compared 
to the strains isolated from the normal individuals (p=0.03) as shown in Figure 3.4. However, 
proteinase production of strains isolated from cancer patients with prostheses was not 
significantly different compared to the strains isolated from the normal individuals. When the 
proteinase production by the strains isolated from the denture wearers and cancer patients with 
prostheses were compared, the results showed that strains isolated from the denture wearers 
produced significantly higher amounts (p=0.04).  
 
  
Figure 3.4 Proteinase production by C. albicans isolated from normal subjects, denture 
wearers and cancer patients with oral prostheses. Pr: ratio of the colony diameter and the 
clear zone, therefore lower values indicate greater enzyme activity and 1 indicate no 
enzyme production.   
 
* 
* ** 
** 
*: p= 0.03, **: p= 0.04 
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3.2.5 Summary of results of the pathogenic characteristics of C. albicans  
The summary in Table 3.13 shows the quantitative analysis of germ tube formation, adherence, 
phospholipase and proteinase production by the strains isolated from the study groups. Overall 
there was a statistical difference between the results of study groups. However, when the results 
of the study groups were compared to one another, germ tube formation was found to be higher 
only by the strains from Cancer patients with prostheses compared to the strains from normal 
subjects. The adherence by the strains isolated from the denture wearers and cancer patients with 
prostheses were higher compared to the strains isolated from the normal subjects. However, 
phospholipase and proteinase production by only the strains isolated from the denture wearers 
was higher than the strains isolated from the normal subjects. 
 
Table 3.13 Summary of results from Germ tube formation, adherence to oral epithelial   
cells phospholipase and proteinase production by C. albicans  
 
 
Pathogenic characteristics 
Quantitative analysis 
Mean ± SD 
 
 
Overall 
P value 
Normal 
subjects   
n=20 
Denture 
wearers      
n=20 
Cancer patients 
with prostheses 
n=14 
 
Germ tube formation (%)  
 
41.2 ± 21.85* 
 
43.2 ± 15.11 
 
57.17 ± 17.48* 
 
0.03 
 
Adherence to oral epithelial 
cells (Yeast/100 epithelial 
cells) 
 
343.4 ± 267.6 
**, § 
 
 
694.8 ± 391.44 
** 
 
 
818.71± 286.1 § 
 
 
<0.01 
 
Phospholipase production (Pz) 
 
0.95 ± 0.1¤ 
 
 
0.81 ± 0.16 ¤ 
 
 
1.0 ±0.18 
 
 
<0.01 
 
Proteinase production (Pr) 
 
0.92 ± 0.09 # 
 
 
0.81 ± 0.12 # 
 
 
0.93 ± 0.12 
 
 
0.02 
*: p=0.05, **, §, ¤: p=0.01, #: p=0.03 
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3.2.6 Number of strains isolated from the study groups presented with pathogenic 
characteristics 
The number of strains that produced germ tube, showed adherence ability and produced 
phospholipase and proteinase are shown in Table 3.14 and Figure 3.5. All the strains produced 
germ tube and showed adherence ability. Phospholipase was produced by 25%, 85% and 57.14% 
of the C. albicans strains isolated from normal subjects, denture wearers and cancer patients with 
prostheses respectively. Proteinase was produced by 60%, 80% and 64.29% of the C. albicans 
strains isolated from normal subjects, denture wearers and cancer patients with prostheses 
respectively. When the number of phospholipase producing strains was compared between the 
groups, significant difference was found (p>0.01). However, no difference was found in number 
of strains that produced proteinase (p>0.05).     
Table 3.14 Number of strains isolated from the study groups presented with pathogenic 
characteristics 
Pathogenic characteristics No. of strains 
(%) 
 
 Normal 
subjects   
n=20 
Denture 
wearers      
n=20 
Cancer patients 
with prostheses 
n=14 
Overall 
P value 
Germ tube formation  20 (100) 20 (100) 14 (100) >0.05 
Adherence to oral epithelial 
cells  
20 (100) 20 (100) 14 (100) >0.05 
Phospholipase production  5 (25)*,** 17 (85)* 8 (57.14)** <0.01 
Proteinase production  12 (60) 16 (80) 9 (64.29) >0.05 
*: p<0.01, **:p=0.05 
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Figure 3.5 Number of strains isolated from the study groups produced virulence factors 
 
 
3.3. Candida counts and virulence factors 
Candida counts and the results of the pathogenic characteristics of C. albicans strains isolated 
from the study groups are presented in the Table 3.15. 
 
 
 
 
 
 
 
 
* 
** 
* 
** 
*:p<0.01, **: p=0.05 
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Table 3.15 Comparison of counts and the virulence factors of C. albicans strains isolated 
from normal subjects with denture wearers and cancer patients with prostheses 
Study 
groups 
Comparison of parameters of normal subjects to study groups 
C. albicans 
counts 
Germ tube 
formation 
Adherence 
ability 
Phospholipase 
production 
Proteinase 
production 
Denture 
wearers (35) 
High  
(15 with 
>1000 
cfu/ml) 
* High 
(p=0.01) 
Quantity: High    
(p<0.01) 
Quantity High 
(p=0.03) 
No. of strains: 
High (p<0.01) 
No. of strains:  
* 
Cancer 
patients with 
prostheses 
(19) 
High 
(12 with 
>1000 
cfu/ml) 
High 
(p=0.05) 
High 
(p<0.01) 
Quantity: 
* 
Quantity: 
* 
No. of strains: 
High (p=0.05) 
No. of strains:  
* 
*: p=>0.05 (not significant) 
 
 
The C. albicans counts were higher (>1000 cfu/ml) in the denture wearers (15/35 patients) and 
cancer patients (12/19 patients) with prostheses compared to the normal subjects 0/49 patients). 
Even though all the strains isolated from all the study groups produced germ tube, strains 
isolated from the cancer patients with prostheses produced greater quantities of germ tubes 
compared to the strains isolated from the normal subjects (p=0.05). 
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All the strains isolated from all the study groups showed adherence ability, but strains isolated 
from the denture wearers and cancer patients with prostheses showed greater adherence ability to 
the epithelial cells (p=0.01) compared to the strains isolated from the normal subjects. 
 
Many strains isolated from the denture wearers produced higher quantities of phospholipase 
compared to the strains isolated from the normal subjects (p<0.01). Although many strains of C. 
albicans isolated from cancer patients with prostheses produced phospholipase (p=0.05), the 
quantities of the enzyme was not significantly different from the strains isolated from normal 
subjects. 
 
Strains isolated from the denture wearers produced higher amounts of proteinase compared to the 
strains isolated from the normal subjects (p=0.03). The quantities of the enzyme produced by the 
C. albicans isolated from cancer patients with prostheses were not significantly different from 
the strains isolated from normal subjects. 
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CHAPTER 4 
DISCUSSION  
4.1 Normal subjects and Candida species 
Candida species, particularly C. albicans is a commensal carried by many normal healthy 
individuals in their gut, skin, female vagina and oral cavity as shown in this study as well. If 
opportunity is given, these commensals can cause infections. . In our study, the prevalence of C. 
albicans in normal subjects was 42.86% (Table 3.4).  Similar results of 40-50% in healthy individuals 
were reported in the studies of Chavasco et al., 2006, Martinez et al., 2002, Ariyawardana et al., 2006. A 
previous South African study found prevalence of 63% from 100 normal healthy subjects (Patel et al, 
2006). The prevalence of Candida count was also found to be low in this study. In this study 42.86% of 
normal subjects hadCandida count of >1000 cfu/ml as compared to the previous study, where 71.4% of 
normal subjects carried >1000 cfu/ml of Candida. In addition, only C. albicans strains were isolated from 
our normal subjects whereas in other studies,Candida species other than C. albicans (C. dubliniensis, C. 
parapsilosis, C. tropicalis) were observed (Ariyawardana et al, 2006, Patel et al, 2006). 
 
4.2 Denture wearer and Candida species 
It is generally known that the presence of dentures increases the number of microorganisms in 
the oral cavity. In addition to the dentures, many etiological factors contribute towards this 
colonization. They are co-morbidity such as diabetes and HIV infection, systemic illnesses, high 
carbohydrate intake and the actual denture hygiene (Samaranayake et al, 2002). Among these 
microorganisms many denture wearers carry Candida in their oral cavity. Therefore they are 
predisposed to oral candidiasis i.e. denture-associated denture stomatitis (Samaranayake et al, 
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2002). It occurs due to accumulation of microbial plaque with yeasts and bacteria on the fitting 
surfaces of the denture and the underlying mucosa. In this study, the factors that influence the 
oral colonization with Candida in the denture wearers were not considered because prevalence of 
Candida was not our primary objective. However, since the strains of C. albicans required for 
this study had to be isolated from denture wearers, many patients were screened which generated 
the reported data. The results showed that 74.3% of the denture wearers carried Candida in their 
oral cavity compared to 42.9% of normal subjects without any prostheses in their mouth (Table 
3.4) and the difference was significant. Candida carriage in our study population of denture 
wearer was slightly higher than Candida carriage of other studies. The study conducted by 
Daniluk et al., (2006), showed the prevalence of Candida carriage in the oral cavity of denture 
wearers to be 66.7% whereas Chopde et al., (2012), reported 55.4%. The increase in the 
prevalence of Candida carriage in our study group could be due to the other contributing factors 
such as HIV, diabetes, nighttime wearing of dentures and systemic illnesses (Gendreau and 
Loewy, 2011)  that were not considered in this study. Furthermore, the mean age of denture 
wearers in our study population was 75 years which might have influenced the carrier rate (Table 
3.2). Candida carriage is generally higher in elderly people (Akpan and Morgan, 2002). 
 
The results of this study showed not only the high prevalence of multiple Candida carriage but 
also the very high (mean count of 18616 cfu/ml) Candida counts which was performed on oral 
rinses collected while patients were wearing dentures. Abaci et al., (2010) reported that when the 
count of Candida species in saliva is > 400 cfu/ml, then frequency of development of denture 
related stomatitis increased (Abaci et al, 2010). In our study group, 25 (71.63%) colonized 
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patients carried ≥100 cfu/ml of which 15(42.86%) patients carried >1000 cfu/ml which suggest 
that these patients are at high risk of oral candidiasis development. 
 
Candida albicans was the predominant species isolated from the denture wearers (46%). Similar 
results have been reported by Cavaleiro et al., (2013). Patients with locator-retained overdenture 
and bar-retained overdentures also carry predominantly C. albicans in their oral cavity (Kilic et 
al., 2014). Candida albicans is known to be more virulent than other Candida species because of 
its ability to produce virulence factors including production of destructive hydrolytic enzymes, 
hyphae formation and ability to adhere to the oral epithelial cells (Silva et al., 2012). However, 
more recently pathogenesis of Candida other than C. albicans is emerging. Yeasts such as C. 
glabrata, C. tropicalis, C. krusei and C. parapsilosis have been isolated from blood stream and 
urinary tract infections (Giri and Kindo, 2012, Kauffman et al., 2011).   
 
Candida glabrata (26.5%) was the second most common Candida species isolated from denture 
wearers (Table 3.6), similar to the results obtained by Coco et al., (2008) and Loster et al., 
(2012). These authors also reported that mixed infections with C. albicans and C. glabrata were 
correlated to the degree of inflammation suggesting the role of other Candida subspecies in the 
pathogenesis. In addition, C. glabrata has developed resistance to widely used antifungal 
fluconazole and relatively newly developed antifungal echinocandins (Pfaller et al., 2012, Silva 
et al., 2012). Candida glabrata, C. tropicalis, and C. parapsilosis which were also isolated in 
this study are capable of producing biofilms on medical implants and no doubt on dentures 
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(Cuèllar-Cruz et al., 2012). They also produce pseudohyphae and some of the hydrolytic tissue 
destructive enzymes (Silva et al., 2012). These properties can be attributed to pathogenesis of 
these non-Candida species.  In our study, 46% of denture wearers, (Table 3.5) carried multiple 
yeasts which suggest that detection of all types of Candida is important in the management of 
patients particularly patients who do not respond to the antifungal agents.  
 
4.3 Cancer patients with prostheses 
Since oral candidiasis is considered a disease of the diseased, cancer patients most certainly fall 
into this category. The patients with cancers carry Candida in their oral cavity and during cancer 
treatment they develop oral candidiasis. The carriage rate was 49.4%, 64.6% and 36.9% in 
hematological malignancy, solid tumor and head and neck cancers respectively (Schelenz et al., 
2011). However, carriage can increase with the age, duration of illness and treatment, and 
presence of dentures in the mouth (Gammelsrud et al., 2011, Davies et al, 2002). It is known that 
the mere presence of prostheses in the oral cavity predisposes patients to oral infections, cancer 
patients with prostheses are highly vulnerable to oral infection. Furthermore, the prevalence of 
oral candidiasis is normally high in head and neck cancer patients due to the development of 
xerostomia (Bensadoun et al., 2011, Mañas et al., 2012).  
 
Although the study groups were not matched (age, gender, HIV status etc.) in this study, the 
result showed that the Candida carriage rate was significantly high in cancer patients with 
prostheses (84%) compared to the 42.85% of normal subjects (Table 3.4). However, this was not 
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significantly higher than patients with denture (74%) which suggests that in patients with oral 
prostheses, cancer does not increase the carriage rate of Candida. However, Epstein et al., (1993) 
reported that, in cancer patients in the presence and use of oral prostheses were shown to 
correlate with oral colonization of C. albicans before radiation therapy.  
 
The mean counts of Candida in the cancer patients (59084 cfu/ml) compared to the denture 
wearers (18616 cfu/ml) was much higher (Table 3.7) and 63% of cancer patients were carrying 
more than 1000 cfu/ml of Candida (Table 3.8), which suggests that the immune response, 
environmental and physiological factors may have played a significant role. Although the 
salivary flow was not measured in the samples of these patients, xerostomia is known to occur 
and can influence the Candida counts. Improvement in the hygiene of prostheses may decrease 
the number of organisms. However, cancer patients are often too ill to care for their prostheses.  
In addition, secreted IgA is very important in host defense against oral candidiasis and may 
regulate the oral Candida population (Coutinho, 2009). And cancer patients are known to have 
reduced secretory immunoglobulin A (Shpitzer et al., 2007).  
 
Candida other than C. albicans such as C. glabrata, C. tropicalis and C. krusei were isolated 
from cancer patients with prostheses. These non - C. albicans Candida species were also isolated 
from cancer patients by Dahiya et al., 2003, Thaweboon et al., 2008. The role of non - C. 
albicans yeasts in the pathogenesis of oral candidiasis has been identified in recent years and has 
become clinically important. In addition, they may be resistant to many antifungal agents (Silva 
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et al., 2011). When Dahiya et al., (2003) investigated oral candidiasis in cancer patients; they 
found that 3 of 37 patients were infected with non-C. albicans Candida. Redding et al., (2002) 
added that C. glabrata colonization is common in patients receiving radiation treatment for head 
and neck cancer. These results suggest that isolation and identification of Candida species in 
cancer patients is very important for the appropriate treatment which can be instituted without a 
delay. Oral prostheses including dentures are mostly prepared using acrylic resin which also 
allows adherence of C. glabrata and this may have been the reason why this species was isolated 
from both study groups (Zamperini et al., 2012). 
 
Oral cancer patients may undergo a series of treatment including oral prostheses due to the 
anatomical abnormalities created by surgical resections. Material such as silicon or polymethyl 
methacrylate, titanium and AO/ASIF stainless steel are used in the reconstructions of patients 
with maxillary and mandibular defects (Harsha et al., 2012, Depprich et al., 2008). Some of these 
materials may increase the risk of colonization of microorganisms which can result in local or 
systemic infections. Not much is known about the bacterial contaminants present on these 
prostheses. Depprich et al., (2008) studied colonization of 36 obturators used by patients and 
found high level of oral and gut flora as well as C. albicans. They also showed that titanium-
based obturators harbored fewer microorganisms than silicon/PMMA (polymethyl methacrylate) 
obturators (Depprich et al., 2008).  
It is clear that many denture wearers and cancer patients carry high numbers of Candida 
including C. albicans in their oral cavity. These high counts may predispose these patients to oral 
candidiasis. However, those colonized by C. albicans may be exposed to infection with the aid of 
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virulence factors such as hyphae formation, adherence ability and the production of hydrolytic 
enzymes. Therefore, these virulence factors produced by the strains isolated from the 3 study 
groups were measured and compared.   
 
4.4 Pathogenic characteristics of C. albicans isolated from the study groups 
The virulence factors expressed by Candida may vary, depending on the type, stage and site of 
infection such as superficial or deep sited and the nature of the host immunity (Mohan das and 
Ballal, 2008). Germ tube formation, the production of hydrolytic enzymes and ability to adhere 
to epithelial cells are known to contribute in the pathogenesis of C. albicans (Haynes, 2001, 
Calderone and Fonzi, 2001). Host-Candidal interaction is best studied in the host which can be 
an animal. However, some of these virulence factors are measurable in the laboratory 
environment (Pinto et al., 2008, Lyon and de Resende, 2006, Ramla et al., 2015) and therefore 
virulence factors of C. albicans isolated during commensal state were measured in this study and 
compared between the study groups. 
 
4.4.1 Germ Tube formation and Adhesion 
Germ tube formation is the initial stage in the yeast-hyphal transition. The presence of hyphae 
seems to facilitate the candidal colonization on the mucosal surfaces and raises the C. albicans 
counts (Bilhan et al., 2008). All the strains of C. albicans isolated from all the study subjects 
produced germ tube (Figure 3.5). However quantitative analysis showed that higher number of 
yeast cells isolated from cancer patients with prostheses produced germ tubes compared to the 
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strains isolated from the normal subjects (Figure 3.1). High number of C. albicans isolated from 
HIV positive patients have shown to produce germ tubes (27.5%) compared to the 14.7% of the 
healthy individuals (Wibawa et al., 2015).  These results are contradictory to those reported by 
Ramla et al., (2015) who found no difference in the germ tube formation between the strains 
isolated from normal subjects and cancer patients either on radiotherapy or chemotherapy. 
Chemotherapy has been reported to increase the hyphal formation (Moussa et al., 1990) and 
decrease the germ tube formation (Land et al., 1980). Based on the germ tube and Candida 
counts (Table 3.15) results obtained in this study suggest that the strains isolated from the cancer 
patients have a greater potential to cause infection.  
  
Although germ tube formation is important in the disease process, all the virulence factors are 
not required at all the stages of infection (Naglik et al., 2003). Nevertheless, germ tube formation 
is important in the oral and vaginal infections and in some other invasive infections.  
In the invasive candidiasis, germ tube antibodies are detectable using the Immunofluorescent 
IgG test. Germ tube cell wall surfaces contain 230-250 kDa mannoprotein which acts as an 
antigen and during infection, patients develop antibodies against this antigen. However, often in 
very ill patients early detection of this antibodies and treatment with antifungal agents can reduce 
mortality (Perman et al., 2011). This suggests that it would be interesting to investigate antibody 
levels in denture patients with and without stomatitis as well as cancer patients with and without 
mucositis. 
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The adhesion of Candida cells to host mucosal surface is a vital prerequisite for successful 
colonization and infection (Cannon et al., 1995). C. albicans adheres to host cells more than any 
other species of Candida. In this study, C. albicans strains isolated from the denture wearers as 
well as cancer patients had significantly higher level of adherence to buccal epithelial cells than 
strains isolated from normal subjects (Figure 3.2). Similarly C. albicans isolated from the HIV 
positive patients and patients with diabetes mellitus have shown increased adherence ability 
(Sweet et al., 1995, Manfredi et al., 2006). Adherence allows yeast cells the chance to proliferate 
and colonize the host, with or without signs or symptoms of infection (Calderone and Fonzi, 
2001). The balance between colonization and overt infection may be tipped toward infection in 
compromised individuals by changes in the expression of adherence ligands and receptors. This 
explains the high counts of Candida and the greater ability to adhere in the denture wearers and 
cancer patients with prostheses (Table 3.7 and Table 3.10). 
 
Wearing prostheses was the common factor in denture wearers and the cancer patients for 
Candida carriage. Acrylic dentures are known to act as reservoir for microorganisms including 
Candida and therefore play an important role in the development of Candidiasis. Silicone and 
PMMA made prostheses obturators are also known to become colonized with Candida 
(Depprich et al., 2008). In addition, pores, cracks and structural defects allow penetration and 
therefore persistence of Candida into these prostheses (Glass et al., 2001). This explains the high 
counts found in the oral cavities of these two groups.  
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Adherence of C. albicans to plastic medical devices (medical implants, prostheses and catheters) 
allows the organism to propagate and establish biofilms to release microorganisms from these 
biofilms which contributes to or initiates acute disseminated nosocomial infections. Several 
components of the microfibrillar surface layer of C. albicans are implicated in plastic binding 
and plastic adherence and appear to be mediated by cell surface hydrophobicity (CSH) through 
hydrophobic bonds between the plastic surface and the peptide moieties of the mannoproteins. 
These mannoproteins may play other significant roles in cell physiology rather than specifically 
bind to plastic surfaces. Salivary proteins, adsorbed to plastic material of dental or voice 
prostheses may also help colonization by fungal cells (Mishra et al., 2007).  
 
In the oral cavity, saliva mechanically clears food debris and microorganisms. In addition, 
adhesion and colonization of C. albicans is generally suppressed by saliva from healthy persons 
due to the antimicrobial compounds such as lactoferrins, lactoperoxidases and specifically 
antifungal compounds histatins and defensins (Yamagishi et al., 2005, Umazume et al., 1995). In 
cancer patients, salivary secretion is greatly suppressed by cancer therapy which might also be 
responsible for the higher counts of Candida. In addition, whole salivary glycoproteins and 
released glycans also inhibit the interaction of C. albicans with buccal epithelial cells (Everest-
Dass et al., 2012).  
 
Increased adherence ability of the strains isolated from these two groups suggests that even 
during the colonization state these strains shows readiness to cause infection. In recent years, a 
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novel approach of therapy, targeting virulence factors rather than the conventional antifungal 
approach has been suggested (Gauwerky et al., 2009). Therefore, development of chemical 
agents that can prevent the adherence mechanisms may be a better therapeutic agent in the 
maintenance of reduced quantity of Candida in the oral cavity rather than the use of fungicidal 
agents.  
 
4.4.2 Phospholipase and proteinase production 
Phospholipases are a heterogeneous group of enzymes that share the ability to hydrolyze one or 
more ester linkage in glycerophospholipids. They can effectively degrade the membrane of the 
host cells leading to cell lysis and death. Both the adherence of Candida to receptor sites and its 
subsequent penetration of damaged tissue can be facilitated by this process (Williams and Lewis, 
2011). They are considered putative virulence factors because they are associated with adhesion 
to epithelial cells, host cell penetration, invasion of epithelial cells, and interaction with host 
signal transduction pathways (Schaller et al., 1999, Mishra et al., 2007). Experiments involving 
the disruption of a gene that encodes for a phospholipase showed a decrease in virulence and a 
reduced ability of C. albicans to penetrate host cells. This suggests that phospholipases plays a 
role in causing damage to host cell (Leidich et al., 1998, Khan et al., 2010).  
 
In this study, phospholipase production was significantly high in strains of C. albicans isolated 
from denture wearers compared to the normal subjects (Figure 3.3). There was no significant 
difference in phospholipase production by strains isolated from cancer patients and the normal 
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subjects. These results with cancer patients are contradictory to the results obtained by Ramla et 
al., (2015). They found that many strains of C. albicans isolated from the cancer patients 
produced high quantities of phospholipase compared to the strains from normal subjects. 
Although the production of hydrolytic enzymes is one of the mechanisms in the pathogenesis, 
not all clinical strains necessarily produce these enzymes (Kantarcioglu and Yucel, 2002). In this 
study, 85% of strains isolated from denture wearers, 57.14% from cancer patients and 25% from 
normal subjects produced phospholipase (Table 3.14). When Abaci (2011) compared the 
phospholipase production by strains of C. albicans isolated from denture wearers with and 
without stomatitis, they found no significant difference in phospholipase producing strains. 
Similar results were also found by Kadir et al., (2007) but they found higher quantities of 
phospholipase in the strains isolated from the patients with stomatitis. In contrast Marco-Arias et 
al., (2009) reported that phospholipase producing strains were significantly higher in patients 
with Newton’s type II and III classified denture stomatitis compared to the commensal state. 
Similarly C. albicans isolated from HIV positive and HIV negative patients have shown no 
difference in the phospholipase production (Mane et al., 2012, Patel et al., 2009). 
 
Phospholipases are also produced by the strains isolated from normal individuals as also shown 
in our study (25%). Strains of C. albicans isolated from the anatomical sites of healthy humans 
produce different amounts of phospholipases. Oksuz et al., (2007) reported that phospholipase 
activity is higher in oral and fecal isolates of C. albicans compared to other anatomical sites. 
Despite these contradictory results, it is clear that during invasive infection and serious illnesses 
the amount of phospholipase production increases and it increases the mortality rate (Ibrahim et 
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al., 1995). This suggests that the role of extracellular phospholipase production by Candida in 
pathogenic processes cannot be ignored and requires further research.  
 
Secreted aspartic proteinases (SAPs) are secreted by pathogenic species of Candida including C. 
albicans during infection. They are responsible for the adhesion, tissue damage and invasion of 
host immune responses. Proteinases fulfill a number of specialized functions during the infective 
process. They include digesting molecules for nutrient acquisition, digesting or distorting host 
cell membranes to facilitate adhesion and tissue invasion, and digesting cells and molecules of 
the host immune system to avoid or resist antimicrobial attack by the host (Mohan das and 
Ballal, 2011). These researchers postulated that proteinases may act on the epithelial tissues 
whereby it may uncover sites on the tissue in order for the fungal cells to adhere and hence 
penetrate (Kwon-Chung et al., 1985). As phospholipases and aspartyl proteinases of C. albicans 
are considered important virulence factors, the absence or lowered expression of these enzymes 
may indicate the less virulent nature of Candida species, when compared to Candida species 
with higher expression of these enzymes, particularly in immunosuppressed patients, and the 
degree of virulence and pathogenicity are correlated with the level of secreted proteinases, 
(Mohan das and Ballal, 2008 and Akçağlar et al., 2011). 
 
In the present study, strains isolated from denture wearers produced significantly higher amount 
of proteinase compared to the normal subjects and cancer patients (Figure 3.4). This suggests 
that these strains have greater potential to cause infection. In the literature results of proteinase 
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activity are controversial. It has been reported that strains of C. albicans isolated from patients 
with denture stomatitis produce higher amounts of proteinase compared to the colonizing strains 
isolated from the denture wearers (Koga-Ito et al., 2006, Abaci, 2011). In contrast, Marcos-Arias 
et al., (2009) showed no difference in the proteinase production by strains of C. albicans isolated 
from the denture wearers with and without stomatitis. Similarly, strains of C. albicans isolated 
from patients with type 2 diabetes mellitus produce increased quantities of proteinase compared 
to the strains isolated from normal healthy individuals (Tsang et al., 2007). Manfredi et al, 
(2006) showed no difference in the proteinase production by the strains isolated from diabetic 
patients and normal individuals. Furthermore similar controversial results have been reported in 
HIV positive patients (Mane et al., 2012, Ollert et al., 1995, Patel et al., 2009). 
 
Although the drugs used in chemotherapy and radiation (in vitro study) has shown to increase the 
production of proteinase by C. albicans, no difference in the proteinase production was found 
between the strains isolated from normal subjects and cancer patients on either cancer therapy 
(Ueta et al., 2001, Ramla et al., 2015). Similarly in this study no difference was found in the 
production of proteinase between the strains isolated from normal subjects and cancer patients 
with oral prostheses.  
 
In C. albicans, 10 SAPs have been identified but their role in the commensal state is not known. 
These SAPs are produced at different stages of infections and the production is also associated 
with the morphological state of C. albicans. In vitro studies have reported that SAPs 1, 2 and 3 
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are expressed by the yeast phase, only while SAPs 4, 5 and 6 are expressed in the hyphal phase. 
In addition, environmental factors and host factors also influence the production of these 
enzymes (Naglik et al., 2003). Proteinase detection tests performed in the laboratory 
environment are not uniform across the laboratories and they not very accurate which could be 
the reasons for the controversial results in the literature. Molecular techniques with the detection 
of gene expression may prove to be more accurate.     
 
4.5. Role of Immune response 
Candidiasis may occur due to immunological dysfunction of the host as well as due to the 
expression of infection-associated genes. The products of these genes contribute to fungal 
pathogenicity and are described as virulence factors. These virulence factors are required at 
different stages of infection (Khan et al., 2010). Therefore the virulence factors of C. albicans 
isolated from the two susceptible groups were measured and compared to the normal healthy 
subjects. The summary of these results are shown in Table 3.15. 
 
The host defense against Candida infection depends on the early activation of innate immunity 
cells such as neutrophils, followed by a specific immune response that is mediated by 
lymphocytes (Gasparoto et al., 2010, Netea and Marodi, 2010). This process is initiated by the 
recognition of chemical structures called pathogen-associated molecule patterns (PAMPs), 
present on the invading pathogen by pattern recognition receptors (PRRs), such as CD206, 
TLR2, TLR4 and Dectin-1 (Gasparoto et al., 2010, Netea and Marodi, 2010, Tessarolli et al, 
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2009). Neutrophils have been shown to influence the innate immune response in the oral mucosa 
(Netea et al., 2008, Schaller et al., 2004). Adherence of C. albicans to the oral epithelial cells is 
the initial stage of proliferation, colonization and the infection. The counts and the adherence 
ability were increased in the C. albicans isolated from denture wearers and cancer patients with 
prostheses suggest that this early activation of innate immunity may have been compromised 
(Table 3.15). In cancer patients, the cancer therapy causes myelosuppression and damage to the 
mucosal barrier which is known to increase the adherence property of these organisms 
(Bensadoun et al., 2011). Furthermore, secreted IgA is important in regulation of Candida 
colonization and host defense against oral candidiasis (Coutinho HDM, 2009) and the reduced 
secretory IgA in cancer patients, (Shpitzer et al., 2007), may have been responsible for the high  
Candida counts in these patients.  
 
The activation of neutrophils and phenotypic modulation which is the first defense is impaired by 
age (Ginaldi et al., 2001) which may increase the chances of Candida infections in older people. 
In this study, the average age of denture wearers and cancer patients with prostheses was 75 and 
70 respectively (Table 3.2 and 3.3). This suggests that both groups were possibly defective in the 
early activation of innate immunity and may have reduced expression of salivary CD66b, CD64 
and blood, and salivary TLR2 (Gasparoto et al., 2012).  
 
Many strains of C. albicans isolated from denture wearers produced high quantities of 
phospholipase and proteinase. Whereas, only the number of phospholipase producing strains 
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isolated from cancer patients with prostheses were high and they produced low quantities of this 
enzyme.  The reason for the difference in the results of denture wearers and cancer patients 
cannot be explained. Nevertheless, in the denture wearers, high quantities of enzymes produced 
by many of the strains collectively may accelerate the development of infection. It also suggests 
that hygiene of the oral cavity, dentures and the prostheses is important in the reduction of 
number of Candida and hence prevention of oral candidiasis. Proper cleaning and regular use of 
mild antimicrobial mouth rinses can keep the number of Candida low. Triclosan containing 
mouth rinses are known to reduce the number of Candida in the oral cavity (Patel et al., 2008).  
 
Both the groups were aged and carried prostheses. Therefore, age related factors such as low 
salivary flow and medications for hypertension etc. and factors related to the prostheses such as 
hygiene could have been the same in the two groups. Larger sample size, data regarding risk 
factors and more sensitive techniques for the proteinase production may have explained these 
results. 
   
4.6 Future Research 
1 In cancer patients often mucositis and candidiasis is not differentiated which causes delay 
in the appropriate treatment. The use and the efficacy of the germ tube antibody test in 
the cancer patients with mucositis could be researched. This test is much quicker than the 
culture technique. 
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2 Antifungal drugs are frequently used by the denture wearers and cancer patients. C. 
albicans is developing resistance towards antifungal drugs (Perlin, 2010). Not much data 
is available in the strains isolated from South Africa. Therefore antifungal susceptibility 
tests can be performed to detect any drug resistance.  
3 Candida species other than C. albicans are often isolated from the oral cavities of denture 
wearers and cancer patients and they are generally resistant to antifungal drugs. However. 
Their ability to produce virulence factors and their role in the development of oral 
infection is not known which can be studied.  
4 Using a large sample size, multiple risk factors for the colonization and development of 
infection can be assessed and compared to the Candida counts, types of Candida and 
their virulence factors. 
5 More sensitive and accurate tests for the production of hydrolytic enzymes by C. albicans 
can be developed 
 
4.7 Limitations of the study 
1 It is known that quantity of saliva affects Candida counts and therefore collection of 
saliva in these patients in a specific time period would have been ideal. However, many 
of these patients had xerostomia and the collection of saliva was not possible. Therefore, 
oral rinse was collected and the Candida counts could not be compared with quantity of 
saliva. 
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2 Many factors such as age, HIV status, systemic illnesses, denture-stomatitis, related 
medications, type of cancer and prostheses, and oral hygiene can influence the carriage 
rate in patients with dentures and cancers as well as normal subjects. However, the 
primary objective of this study was not “the comparison of carriage rate or prevalence of 
Candida” in these study groups. The average age of denture wearers and cancer patients 
with prostheses was 70-75 years and it was difficult to match with normal healthy 
subjects with that age. There were many issues with the HIV status of the study 
population. For example, if the patient is HIV positive, they are not obliged to reveal their 
status. If the patient did not know their HIV status there were consenting, costing for the 
test and counselling implications. This would have created 3 groups of results such as 
HIV positive, HIV negative and unknown within a small sample of 20 patients.   
3 Molecular techniques applied directly to the oral rinse collected from the study subjects 
may have partially answered the research question regarding the production of germ tube 
and hydrolytic enzymes. They would have been accurate and sensitive but in this project 
it would have been disadvantageous in many aspects. They would have increased the cost 
of study tremendously; they would not have given the quantities of enzymes (Pz & Pr), 
types of Candida and their counts. Probably for these reasons techniques applied in this 
study are widely used (Mane et al., 2012, Ueta et al., 2001, Ramla et al., 2015, Kadir et 
al., 2007, Manfredi et al., 2006). 
 
4.8. Conclusions 
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Many denture wearers and cancers patients with prostheses carried higher numbers of Candida 
compared to normal subjects. C. albicans was the predominant species however, Candida other 
than C. albicans such as C. glabrata and C. tropicalis were also isolated from the oral cavities of 
denture wearers and cancer patients with prostheses. Although the germ tube formation was 
significantly (weak) increased in the strains isolated from cancer patients with prostheses 
compared to the isolates from normal subjects, all the strains isolated from the study groups 
produced germ tube which suggest that germ tube is not a good factor for the measurement of 
virulence.   
 
Adherence to epithelial cells was significantly increased in strains isolated from denture wearers 
and cancer patients with prostheses compared to the isolates from normal subjects. Adherence is 
the initial stage in the proliferation, colonization and the infection. The counts and the adherence 
ability was increased in the C. albicans isolated from these two groups suggest that this early 
activation of innate immunity may have been compromised. Many strains of C. albicans isolated 
from denture wearers produced phospholipase and proteinase and the quantities of these enzymes 
were also high compared to the strains isolated from the normal subjects. These results suggest 
that strains isolated from denture wearers had more potential or readiness to cause infection. Due 
to the high quantities and many enzyme producing strains, collectively these enzymes may 
accelerate the development of infection in this study group. 
 
CHAPTER 5 
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CHAPTER 6 
 
APPENDICES 
 
6.1 Composition and preparation of media and reagents 
 
ChromAgar plate (CHROMagar, Paris, France) 
65g Chromagar powder 
1000ml dH2O 
Preparation Method: Dissolve Chromagar powder in sterile distilled water; bring it to boil 
while stirring. Let it cool to 45-50°C and pour plates under laminar flow. Do not 
autoclave. 
 
0.5% Coomassie brilliant blue (Pierce Biotechnology) 
0.5g Coomassie blue 
45ml Ethanol 
10ml Acetic acid 
Preparation method: Weigh Coomassie blue powder; mix it with ethanol then acid. Keep 
it at room temperature. 
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Destaining solution 
45ml Ethanol 
45ml dH2O 
10ml Acetic acid 
Preparation method: Mix distilled water with ethanol then acetic acid. Keep it at room 
temperature. 
Egg yolk media 
13g Sabouraud agar 
11.7g NaCl 
0.11g CaCl2 
20ml Egg Yolk Emulsion 
184ml dH2O 
Preparation Method: Dissolve SAB agar, NaCl, CaCl2 in dH2O and autoclave. Cool to 
45
o
C, add egg yolk emulsion, mix gently and pour plates. 
Saboraud (SAB) Agar 
65g Saboraud agar 
1000ml distilled H2O 
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Preparation Method: Suspend SAB agar in distilled water. Heat half the water to a boiling 
point. Dissolve the powder in water and add to the boiling water. Add the rest of the 
water and heat to boiling point. Pour into large bottles and sterilize at 121b for 15min in 
autoclave 
SAB broth (pH 5.6) 
4% Dextrose 
1% Peptone 
5.0mg Chloramphenicol 
Preparation method: Weigh 65g of SAB powder, dissolve in 1000ml of dH2O. autoclave    
at 121 °C for 15 min.  
YCB-SAB plate 
140 ml of 1.5% Colombia agar 
1.17% Yeast Carbon Base Powder 
0.2% BSA 
0.2% Glucose 
0.5g K2HPO4 
0.04g MgSO4.7H2O 
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Preparation Method: Dissolve above dry ingredients in 60ml distilled water, adjust pH to 
3.5 and filter sterilize. Add this mixture to 140ml sterile Columbia agar medium. Pour 
plates. 
 
6.2  Ethical clearance certificate 
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6.3 Statistical analysis 
Carriage comparison between groups: 
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Stats for Virulence factors: 
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